Loading...
Header Logo
Keywords
Last Name
Institution

DIMITRIOS P KONTOYIANNIS

TitleProfessor
InstitutionMD Anderson
DepartmentInfectious Diseases, Infection Control, and Employee Health
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lewis RE, Kontoyiannis DP, Viale P, Sarpong EM. Using State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral Suspension. Antimicrob Agents Chemother. 2019 Sep 16. PMID: 31527039.
      View in: PubMed
    2. Abers MS, Lionakis MS, Kontoyiannis DP. Checkpoint Inhibition and Infectious Diseases: A Good Thing? Trends Mol Med. 2019 Sep 04. PMID: 31494023.
      View in: PubMed
    3. Lamoth F, Kontoyiannis DP. Therapeutic challenges of non-Aspergillus invasive mold infections in immunosuppressed patients. Antimicrob Agents Chemother. 2019 Sep 03. PMID: 31481441.
      View in: PubMed
    4. Kontoyiannis DP. Is Candida auris here to stay? An interview with Dimitrios Kontoyiannis. Future Microbiol. 2019 Sep; 14:1083-1085. PMID: 31512518.
      View in: PubMed
    5. Wang Q, Kontoyiannis DP, Li R, Chen W, Bu D, Liu W. A Novel Broad Allele-Specific TaqMan Real-Time PCR Method To Detect Triazole-Resistant Strains of Aspergillus fumigatus, Even with a Very Low Percentage of Triazole-Resistant Cells Mixed with Triazole-Susceptible Cells. J Clin Microbiol. 2019 Sep; 57(9). PMID: 31315952.
      View in: PubMed
    6. Galloway-Peña JR, Shi Y, Peterson CB, Sahasrabhojane P, Gopalakrishnan V, Brumlow CE, Daver NG, Alfayez M, Boddu PC, Khan MAW, Wargo JA, Do KA, Jenq RR, Kontoyiannis DP, Shelburne SA. Gut Microbiome Signatures are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia. Clin Infect Dis. 2019 Aug 22. PMID: 31436833.
      View in: PubMed
    7. Casadevall A, Kontoyiannis DP, Robert V. On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds. MBio. 2019 Jul 23; 10(4). PMID: 31337723.
      View in: PubMed
    8. Magira EE, Chemaly RF, Jiang Y, Tarrand J, Kontoyiannis DP. Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study. Open Forum Infect Dis. 2019 Jul; 6(7):ofz247. PMID: 31338382.
      View in: PubMed
    9. Cornely OA, Hoenigl M, Lass-Flörl C, Chen SC, Kontoyiannis DP, Morrissey CO, Thompson GR. Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology. Mycoses. 2019 Sep; 62(9):716-729. PMID: 31254420.
      View in: PubMed
    10. Chikley A, Ben-Ami R, Kontoyiannis DP. Mucormycosis of the Central Nervous System. J Fungi (Basel). 2019 Jul 08; 5(3). PMID: 31288475.
      View in: PubMed
    11. Lewis RE, Wurster S, Beyda ND, Albert ND, Kontoyiannis DP. Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis. Diagn Microbiol Infect Dis. 2019 Jul 05; 114861. PMID: 31427139.
      View in: PubMed
    12. Walsh TJ, Hospenthal DR, Petraitis V, Kontoyiannis DP. Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma. J Fungi (Basel). 2019 Jul 04; 5(3). PMID: 31277364.
      View in: PubMed
    13. Wurster S, Bandi A, Beyda ND, Albert ND, Raman NM, Raad II, Kontoyiannis DP. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris. J Antimicrob Chemother. 2019 Jul 01; 74(7):1904-1910. PMID: 31225606.
      View in: PubMed
    14. Szvalb AD, Kontoyiannis DP. Acute acalculous cholecystitis due to Fusarium species and review of the literature on fungal cholecystitis. Mycoses. 2019 Sep; 62(9):847-853. PMID: 31166627.
      View in: PubMed
    15. Vargas-Cruz N, Reitzel RA, Rosenblatt J, Chaftari AM, Wilson Dib R, Hachem R, Kontoyiannis DP, Raad II. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm. Antimicrob Agents Chemother. 2019 Jul; 63(7). PMID: 31036689.
      View in: PubMed
    16. Chow NA, Toda M, Pennington AF, Anassi E, Atmar RL, Cox-Ganser JM, Da Silva J, Garcia B, Kontoyiannis DP, Ostrosky-Zeichner L, Leining LM, McCarty J, Al Mohajer M, Murthy BP, Park JH, Schulte J, Shuford JA, Skrobarcek KA, Solomon S, Strysko J, Chiller TM, Jackson BR, Chew GL, Beer KD. Hurricane-Associated Mold Exposures Among Patients at Risk for Invasive Mold Infections After Hurricane Harvey - Houston, Texas, 2017. MMWR Morb Mortal Wkly Rep. 2019 May 31; 68(21):469-473. PMID: 31145717.
      View in: PubMed
    17. Wurster S, Kumaresan PR, Albert ND, Hauser PJ, Lewis RE, Kontoyiannis DP. Live Monitoring and Analysis of Fungal Growth, Viability, and Mycelial Morphology Using the IncuCyte NeuroTrack Processing Module. MBio. 2019 May 28; 10(3). PMID: 31138745.
      View in: PubMed
    18. Zhang H, Tan J, Kontoyiannis DP, Zhou Y, Liu W, Zhu P, Shi X, Wan Z, Li R, Liu W. Screening the in vitro susceptibility of posaconazole in clinical isolates of Candida spp. and Aspergillus spp. and analyzing the sequence of ERG11 or CYP51A in non-wild-type isolates from China. Diagn Microbiol Infect Dis. 2019 Oct; 95(2):166-170. PMID: 31174994.
      View in: PubMed
    19. Mason MJ, McDaneld PM, Musick WL, Kontoyiannis DP. Serum Levels of Crushed Posaconazole Delayed-Release Tablets. Antimicrob Agents Chemother. 2019 May; 63(5). PMID: 30803970.
      View in: PubMed
    20. Stanzani M, Vianelli N, Cavo M, Kontoyiannis DP, Lewis RE. Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies. J Infect. 2019 Jun; 78(6):484-490. PMID: 30974130.
      View in: PubMed
    21. Tatara AM, Watson E, Albert ND, Kontoyiannis PD, Kontoyiannis DP, Mikos AG. A murine model of cutaneous aspergillosis for evaluation of biomaterials-based local delivery therapies. J Biomed Mater Res A. 2019 Sep; 107(9):1867-1874. PMID: 30882993.
      View in: PubMed
    22. Galloway-Peña JR, Peterson CB, Malik F, Sahasrabhojane PV, Shah DP, Brumlow CE, Carlin LG, Chemaly RF, Im JS, Rondon G, Felix E, Veillon L, Lorenzi PL, Alousi AM, Jenq RR, Kontoyiannis DP, Shpall EJ, Shelburne SA, Okhuysen PC. Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study. Open Forum Infect Dis. 2019 May; 6(5):ofz173. PMID: 31065565.
      View in: PubMed
    23. Kontoyiannis DP, Shah EC, Wurster S, Aitken SL, Graviss L, Raad II, Chemaly RF. Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre- and Post-Hurricane Harvey. Open Forum Infect Dis. 2019 Apr; 6(4):ofz138. PMID: 31024975.
      View in: PubMed
    24. DiPippo AJ, Kontoyiannis DP. Lack of toxicity with long term isavuconazole use in patients with hematologic malignancy. Clin Infect Dis. 2019 03 07. PMID: 30861066.
      View in: PubMed
    25. Wurster S, Lewis RE, Albert ND, Kontoyiannis DP. Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model. Antimicrob Agents Chemother. 2019 02; 63(2). PMID: 30455245.
      View in: PubMed
    26. Alfayez M, Wang SA, Bannon SA, Kontoyiannis DP, Kornblau SM, Orange JS, Mace EM, DiNardo CD. Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype. Leuk Lymphoma. 2019 Aug; 60(8):2025-2033. PMID: 30648453.
      View in: PubMed
    27. Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M. Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon? Front Microbiol. 2018; 9:3245. PMID: 30692970.
      View in: PubMed
    28. Potenza L, Chitasombat MN, Klimko N, Bettelli F, Dragonetti G, Del Principe MI, Nucci M, Busca A, Fracchiolla N, Sciumè M, Spolzino A, Delia M, Mancini V, Nadali GP, Dargenio M, Shadrivova O, Bacchelli F, Aversa F, Sanguinetti M, Luppi M, Kontoyiannis DP, Pagano L. Rhodotorula infection in haematological patient: Risk factors and outcome. Mycoses. 2019 Mar; 62(3):223-229. PMID: 30525252.
      View in: PubMed
    29. Yong MK, Slavin MA, Kontoyiannis DP. Invasive fungal disease and cytomegalovirus infection: is there an association? Curr Opin Infect Dis. 2018 12; 31(6):481-489. PMID: 30299361.
      View in: PubMed
    30. Andrianaki AM, Kyrmizi I, Thanopoulou K, Baldin C, Drakos E, Soliman SSM, Shetty AC, McCracken C, Akoumianaki T, Stylianou K, Ioannou P, Pontikoglou C, Papadaki HA, Tzardi M, Belle V, Etienne E, Beauvais A, Samonis G, Kontoyiannis DP, Andreakos E, Bruno VM, Ibrahim AS, Chamilos G. Author Correction: Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species. Nat Commun. 2018 11 22; 9(1):5015. PMID: 30467313.
      View in: PubMed
    31. Lionakis MS, Lewis RE, Kontoyiannis DP. Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions. Clin Infect Dis. 2018 10 30; 67(10):1621-1630. PMID: 29860307.
      View in: PubMed
    32. Rausch CR, DiPippo AJ, Bose P, Kontoyiannis DP. Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole. Clin Infect Dis. 2018 10 30; 67(10):1610-1613. PMID: 29771293.
      View in: PubMed
    33. DiPippo AJ, Rausch CR, Kontoyiannis DP. Tolerability of isavuconazole after posaconazole toxicity in leukaemia patients. Mycoses. 2019 Jan; 62(1):81-86. PMID: 30230043.
      View in: PubMed
    34. Magira EE, Jiang Y, Kontoyiannis DP. Baseline serum Aspergillus galactomannan index in patients with hematologic malignancy and culture-documented invasive pulmonary aspergillosis: is there a difference among Aspergillus species? Med Mycol. 2018 Oct 19. PMID: 30339235.
      View in: PubMed
    35. De la Hoz A, Foolad F, Gallegos C, Kornblau S, Kontoyiannis DP. Nivolumab-induced encephalitis post allogeneic stem cell transplant in a patient with Hodgkin's disease. Bone Marrow Transplant. 2019 May; 54(5):749-751. PMID: 30323308.
      View in: PubMed
    36. Fernández-Cruz A, Magira E, Heo ST, Evans S, Tarrand J, Kontoyiannis DP. Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes. J Clin Microbiol. 2018 10; 56(10). PMID: 30021823.
      View in: PubMed
    37. Dadwal SS, Kontoyiannis DP. Recent advances in the molecular diagnosis of mucormycosis. Expert Rev Mol Diagn. 2018 10; 18(10):845-854. PMID: 30203997.
      View in: PubMed
    38. Andrianaki AM, Kyrmizi I, Thanopoulou K, Baldin C, Drakos E, Soliman SSM, Shetty AC, McCracken C, Akoumianaki T, Stylianou K, Ioannou P, Pontikoglou C, Papadaki HA, Tzardi M, Belle V, Etienne E, Beauvais A, Samonis G, Kontoyiannis DP, Andreakos E, Bruno VM, Ibrahim AS, Chamilos G. Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species. Nat Commun. 2018 08 20; 9(1):3333. PMID: 30127354.
      View in: PubMed
    39. Magira EE, Jiang Y, Economides M, Tarrand J, Kontoyiannis DP. Mixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre. Mycoses. 2018 Nov; 61(11):861-867. PMID: 30015364.
      View in: PubMed
    40. Sipsas NV, Gamaletsou MN, Anastasopoulou A, Kontoyiannis DP. Therapy of Mucormycosis. J Fungi (Basel). 2018 Jul 31; 4(3). PMID: 30065232.
      View in: PubMed
    41. Lacourt TE, Kavelaars A, Ohanian M, Shah ND, Shelburne SA, Futreal A, Kontoyiannis DP, Heijnen CJ. Patient-reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia. Oncotarget. 2018 Jul 27; 9(58):31244-31252. PMID: 30131851.
      View in: PubMed
    42. Chamilos G, Lionakis MS, Kontoyiannis DP. Reply to Bazaz and Denning. Clin Infect Dis. 2018 06 18; 67(1):157-159. PMID: 29370370.
      View in: PubMed
    43. Strati P, Gabutti C, Thompson PA, Kontoyiannis DP, Ferrajoli A. Cytomegalovirus reactivation can be a cause of DAT-negative hemolytic anemia in patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2019 Feb; 60(2):535-537. PMID: 29911929.
      View in: PubMed
    44. Cornely OA, Kontoyiannis DP. How to prophylax against invasive fungal infections in adult ALL? An unmet need. Mycoses. 2018 Sep; 61(9):646-649. PMID: 29693737.
      View in: PubMed
    45. Kyrmizi I, Ferreira H, Carvalho A, Figueroa JAL, Zarmpas P, Cunha C, Akoumianaki T, Stylianou K, Deepe GS, Samonis G, Lacerda JF, Campos A, Kontoyiannis DP, Mihalopoulos N, Kwon-Chung KJ, El-Benna J, Valsecchi I, Beauvais A, Brakhage AA, Neves NM, Latge JP, Chamilos G. Calcium sequestration by fungal melanin inhibits calcium-calmodulin signalling to prevent LC3-associated phagocytosis. Nat Microbiol. 2018 07; 3(7):791-803. PMID: 29849062.
      View in: PubMed
    46. Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR, Garey KW, Reboli A, Greenberg RN, Apewokin S, Lyon GM, Ostrosky-Zeichner L, Wu AHB, Tobin E, Nguyen MH, Caliendo AM. Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel. Clin Infect Dis. 2018 05 17; 66(11):1678-1686. PMID: 29438475.
      View in: PubMed
    47. Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M. Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon? Front Microbiol. 2018; 9:516. PMID: 29643840.
      View in: PubMed
    48. Rausch CR, Kontoyiannis DP. Prolonged voriconazole treatment in a patient with chronic lymphocytic leukemia resulting in a litany of chronic overlapping toxicities. J Oncol Pharm Pract. 2019 Apr; 25(3):747-753. PMID: 29554829.
      View in: PubMed
    49. Castillo P, Wright KE, Kontoyiannis DP, Walsh T, Patel S, Chorvinsky E, Bose S, Hazrat Y, Omer B, Albert N, Leen AM, Rooney CM, Bollard CM, Cruz CRY. A New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae. Mol Ther Methods Clin Dev. 2018 Jun 15; 9:305-312. PMID: 30038934.
      View in: PubMed
    50. Lacourt TE, Kavelaars A, Galloway-Peña JR, Sahasrabhojane PV, Shah ND, Futreal A, Kontoyiannis DP, Shelburne SA, Heijnen CJ. Associations of inflammation with symptom burden in patients with acute myeloid leukemia. Psychoneuroendocrinology. 2018 03; 89:203-208. PMID: 29414033.
      View in: PubMed
    51. Kontoyiannis DP, Selleslag D, Mullane K, Cornely OA, Hope W, Lortholary O, Croos-Dabrera R, Lademacher C, Engelhardt M, Patterson TF. Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial. J Antimicrob Chemother. 2018 03 01; 73(3):757-763. PMID: 29194488.
      View in: PubMed
    52. Schwartz S, Kontoyiannis DP, Harrison T, Ruhnke M. Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol. 2018 04; 17(4):362-372. PMID: 29477506.
      View in: PubMed
    53. Lamoth F, Kontoyiannis DP. The Candida auris Alert: Facts and Perspectives. J Infect Dis. 2018 01 30; 217(4):516-520. PMID: 29390110.
      View in: PubMed
    54. Liu J, Mouhayar E, Tarrand JJ, Kontoyiannis DP. Fulminant Cryptococcus neoformans infection with fatal pericardial tamponade in a patient with chronic myelomonocytic leukaemia who was treated with ruxolitinib: Case report and review of fungal pericarditis. Mycoses. 2018 Apr; 61(4):245-255. PMID: 29280197.
      View in: PubMed
    55. Kumaresan PR, da Silva TA, Kontoyiannis DP. Methods of Controlling Invasive Fungal Infections Using CD8+ T Cells. Front Immunol. 2017; 8:1939. PMID: 29358941.
      View in: PubMed
    56. Chamilos G, Lionakis MS, Kontoyiannis DP. Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways. Clin Infect Dis. 2018 01 06; 66(1):140-148. PMID: 29029010.
      View in: PubMed
    57. Foolad F, Kontoyiannis DP. Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels. J Antimicrob Chemother. 2018 01 01; 73(1):256-258. PMID: 29121264.
      View in: PubMed
    58. Tatara AM, Kontoyiannis DP, Mikos AG. Drug delivery and tissue engineering to promote wound healing in the immunocompromised host: Current challenges and future directions. Adv Drug Deliv Rev. 2018 04; 129:319-329. PMID: 29221962.
      View in: PubMed
    59. Daver N, Kontoyiannis DP. Checkpoint inhibitors and aspergillosis in AML: the double hit hypothesis. Lancet Oncol. 2017 12; 18(12):1571-1573. PMID: 29208429.
      View in: PubMed
    60. Sagiv O, Thakar SD, Kandl TJ, Kontoyiannis DP, Debnam JM, Esmaeli B. Clinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer. Ophthalmology. 2018 02; 125(2):318-320. PMID: 29128228.
      View in: PubMed
    61. Taj-Aldeen SJ, Gamaletsou MN, Rammaert B, Sipsas NV, Zeller V, Roilides E, Kontoyiannis DP, Henry M, Petraitis V, Moriyama B, Denning DW, Lortholary O, Walsh TJ. Bone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century. Med Mycol. 2017 Oct 01; 55(7):691-704. PMID: 28053147.
      View in: PubMed
    62. Mulanovich V, Kontoyiannis DP. Acute myeloid leukemia and the infectious diseases consultant. Leuk Lymphoma. 2018 06; 59(6):1284-1291. PMID: 28914100.
      View in: PubMed
    63. Economides MP, Ballester LY, Kumar VA, Jiang Y, Tarrand J, Prieto V, Torres HA, Kontoyiannis DP. Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000-2016): Uncommon, with improved survival but still deadly often. J Infect. 2017 12; 75(6):572-580. PMID: 28919347.
      View in: PubMed
    64. McCarthy MW, Kontoyiannis DP, Cornely OA, Perfect JR, Walsh TJ. Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi. J Infect Dis. 2017 08 15; 216(suppl_3):S474-S483. PMID: 28911042.
      View in: PubMed
    65. Kontoyiannis DP. Antifungal Resistance: An Emerging Reality and A Global Challenge. J Infect Dis. 2017 08 15; 216(suppl_3):S431-S435. PMID: 28911044.
      View in: PubMed
    66. Ben Yaakov D, Shadkchan Y, Albert N, Kontoyiannis DP, Osherov N. The quinoline bromoquinol exhibits broad-spectrum antifungal activity and induces oxidative stress and apoptosis in Aspergillus fumigatus. J Antimicrob Chemother. 2017 08 01; 72(8):2263-2272. PMID: 28475687.
      View in: PubMed
    67. Le A, Farmakiotis D, Tarrand JJ, Kontoyiannis DP. Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole? Antimicrob Agents Chemother. 2017 08; 61(8). PMID: 28584138.
      View in: PubMed
    68. Tverdek FP, Heo ST, Aitken SL, Granwehr B, Kontoyiannis DP. Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses. Antimicrob Agents Chemother. 2017 08; 61(8). PMID: 28507111.
      View in: PubMed
    69. Heo ST, Tatara AM, Jiménez-Ortigosa C, Jiang Y, Lewis RE, Tarrand J, Tverdek F, Albert ND, Verweij PE, Meis JF, Mikos AG, Perlin DS, Kontoyiannis DP. Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015. Clin Infect Dis. 2017 Jul 15; 65(2):216-225. PMID: 28379304.
      View in: PubMed
    70. Farmakiotis D, Kontoyiannis DP. Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management. Int J Antimicrob Agents. 2017 Sep; 50(3):318-324. PMID: 28669831.
      View in: PubMed
    71. Kontoyiannis DP, Bassetti M, Nucci M, Capparella MR, Yan JL, Aram J, Hogan PA. Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies. Mycoses. 2017 Oct; 60(10):663-667. PMID: 28597967.
      View in: PubMed
    72. Tatara AM, Watson E, Satish T, Scott DW, Kontoyiannis DP, Engel PS, Mikos AG. Synthesis and Characterization of Diol-Based Unsaturated Polyesters: Poly(diol fumarate) and Poly(diol fumarate-co-succinate). Biomacromolecules. 2017 Jun 12; 18(6):1724-1735. PMID: 28486802.
      View in: PubMed
    73. Gamaletsou MN, Rammaert B, Bueno MA, Sipsas NV, Moriyama B, Kontoyiannis DP, Roilides E, Zeller V, Taj-Aldeen SJ, Henry M, Petraitis V, Denning DW, Lortholary O, Walsh TJ. Aspergillus arthritis: analysis of clinical manifestations, diagnosis, and treatment of 31 reported cases. Med Mycol. 2017 Apr 01; 55(3):246-254. PMID: 27609563.
      View in: PubMed
    74. Galloway-Peña JR, Smith DP, Sahasrabhojane P, Wadsworth WD, Fellman BM, Ajami NJ, Shpall EJ, Daver N, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients. Genome Med. 2017 02 28; 9(1):21. PMID: 28245856.
      View in: PubMed
    75. Lionakis MS, Albert ND, Swamydas M, Lee CR, Loetscher P, Kontoyiannis DP. Pharmacological Blockade of the Chemokine Receptor CCR1 Protects Mice from Systemic Candidiasis of Hematogenous Origin. Antimicrob Agents Chemother. 2017 03; 61(3). PMID: 27993850.
      View in: PubMed
    76. Messina JA, Maziarz EK, Spec A, Kontoyiannis DP, Perfect JR. Disseminated Cryptococcosis With Brain Involvement in Patients With Chronic Lymphoid Malignancies on Ibrutinib. Open Forum Infect Dis. 2017; 4(1):ofw261. PMID: 28480254.
      View in: PubMed
    77. Pemmaraju N, Jain P, Medeiros LJ, Jorgenson JL, Jain N, Willis J, Kontoyiannis DP, Estrov Z, Wierda WG. PET-positive lymphadenopathy in CLL-Not always Richter transformation. Am J Hematol. 2017 04; 92(4):405-406. PMID: 27677095.
      View in: PubMed
    78. Abudayyeh A, Hamdi A, Abdelrahim M, Lin H, Page VD, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Oran B, Chemaly RF, Ahmed S, Abudayyeh I, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Rezvani K. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2017 Feb; 19(1). PMID: 27862740.
      View in: PubMed
    79. Kontoyiannis DP. A Potential Explanation of a Positive Serum ß-Glucan Assay in Mucormycosis. Open Forum Infect Dis. 2016 Oct; 3(4):ofw209. PMID: 27942540.
      View in: PubMed
    80. Kontoyiannis DP, Yang H, Song J, Kelkar SS, Yang X, Azie N, Harrington R, Fan A, Lee E, Spalding JR. Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study. BMC Infect Dis. 2016 12 01; 16(1):730. PMID: 27905900.
      View in: PubMed
    81. Kontoyiannis DP. Infections following allogeneic stem cell transplantation: New concepts, improved insights, and renewed hope for better outcomes. Virulence. 2016 11 16; 7(8):898-900. PMID: 27791470.
      View in: PubMed
    82. Kontoyiannis DP. What to Do for the Asymptomatic Pulmonary Coccidioidal Nodule or Cavity in Immunosuppressed Patients? A Focus in the Recent Coccidioidomycosis Guidelines. Clin Infect Dis. 2017 01 15; 64(2):232-233. PMID: 27986674.
      View in: PubMed
    83. Aitken SL, Kontoyiannis DP, DePombo AM, Bhatti MM, Tverdek FP, Gettys SC, Nicolau DP, Nunez CA. Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia Patient. Pediatr Infect Dis J. 2016 09; 35(9):1040-2. PMID: 27254038.
      View in: PubMed
    84. Osherov N, Kontoyiannis DP. The anti-Aspergillus drug pipeline: Is the glass half full or empty? Med Mycol. 2017 Jan 01; 55(1):118-124. PMID: 27562862.
      View in: PubMed
    85. Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE. Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 08 15; 63(4):433-42. PMID: 27481947.
      View in: PubMed
    86. Chitasombat MN, Kontoyiannis DP. Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents. Curr Opin Infect Dis. 2016 08; 29(4):340-5. PMID: 27191199.
      View in: PubMed
    87. Jain P, Nagarajan P, Prayag P, Benton CB, Kadia T, Groisberg R, Kontoyiannis DP, Mulanovich VE, Pemmaraju N. Mixed angioinvasive exserohilum and scedosporium infection in a patient with AML. Am J Hematol. 2017 Jan; 92(1):119-120. PMID: 27341684.
      View in: PubMed
    88. Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 08 15; 63(4):e1-e60. PMID: 27365388.
      View in: PubMed
    89. Tverdek FP, Kofteridis D, Kontoyiannis DP. Antifungal agents and liver toxicity: a complex interaction. Expert Rev Anti Infect Ther. 2016 08; 14(8):765-76. PMID: 27275514.
      View in: PubMed
    90. Kyvernitakis A, Azzi J, Kontoyiannis DP. Mixed Mycobacterium Avium-Intracellulare and Serratia Marcescens Cellulitis of the Breast in an HIV-Negative Patient with Breast Cancer: A Case Report. Cureus. 2016 Jun 09; 8(6):e634. PMID: 27433413.
      View in: PubMed
    91. Tatara AM, Mikos AG, Kontoyiannis DP. Factors affecting patient outcome in primary cutaneous aspergillosis. Medicine (Baltimore). 2016 Jun; 95(26):e3747. PMID: 27367980.
      View in: PubMed
    92. Gebremariam T, Lin L, Liu M, Kontoyiannis DP, French S, Edwards JE, Filler SG, Ibrahim AS. Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis. J Clin Invest. 2016 06 01; 126(6):2280-94. PMID: 27159390.
      View in: PubMed
    93. Galloway-Peña JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji SS, Pemmaraju N, Garcia-Manero G, Rezvani K, Alousi AM, Wargo JA, Shpall EJ, Futreal PA, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer. 2016 07 15; 122(14):2186-96. PMID: 27142181.
      View in: PubMed
    94. Stempel JM, Farmakiotis D, Tarrand JJ, Kontoyiannis DP. Time-to-reporting of blood culture positivity and central venous catheter-associated Candida glabrata fungemia in cancer patients. Diagn Microbiol Infect Dis. 2016 Jul; 85(3):391-393. PMID: 27133559.
      View in: PubMed
    95. Healey KR, Zhao Y, Perez WB, Lockhart SR, Sobel JD, Farmakiotis D, Kontoyiannis DP, Sanglard D, Taj-Aldeen SJ, Alexander BD, Jimenez-Ortigosa C, Shor E, Perlin DS. Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance. Nat Commun. 2016 Mar 29; 7:11128. PMID: 27020939.
      View in: PubMed
    96. Bellanger AP, Tatara AM, Shirazi F, Gebremariam T, Albert ND, Lewis RE, Ibrahim AS, Kontoyiannis DP. Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae. J Infect Dis. 2016 07 01; 214(1):114-21. PMID: 26984141.
      View in: PubMed
    97. Nigo M, Vial MR, Munita JM, Jiang Y, Tarrand J, Jimenez CA, Kontoyiannis DP. Fungal empyema thoracis in cancer patients. J Infect. 2016 May; 72(5):615-21. PMID: 26945845.
      View in: PubMed
    98. Shirazi F, Ferreira JA, Stevens DA, Clemons KV, Kontoyiannis DP. Biofilm Filtrates of Pseudomonas aeruginosa Strains Isolated from Cystic Fibrosis Patients Inhibit Preformed Aspergillus fumigatus Biofilms via Apoptosis. PLoS One. 2016; 11(3):e0150155. PMID: 26930399.
      View in: PubMed
    99. Farmakiotis D, Kontoyiannis DP. Mucormycoses. Infect Dis Clin North Am. 2016 Mar; 30(1):143-63. PMID: 26897065.
      View in: PubMed
    100. Ben Yaakov D, Rivkin A, Mircus G, Albert N, Dietl AM, Kovalerchick D, Carmeli S, Haas H, Kontoyiannis DP, Osherov N. Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis. J Antimicrob Chemother. 2016 Apr; 71(4):946-52. PMID: 26747101.
      View in: PubMed
    101. Akoumianaki T, Kyrmizi I, Valsecchi I, Gresnigt MS, Samonis G, Drakos E, Boumpas D, Muszkieta L, Prevost MC, Kontoyiannis DP, Chavakis T, Netea MG, van de Veerdonk FL, Brakhage AA, El-Benna J, Beauvais A, Latge JP, Chamilos G. Aspergillus Cell Wall Melanin Blocks LC3-Associated Phagocytosis to Promote Pathogenicity. Cell Host Microbe. 2016 Jan 13; 19(1):79-90. PMID: 26749442.
      View in: PubMed
    102. Gamaletsou MN, Rammaert B, Bueno MA, Sipsas NV, Moriyama B, Kontoyiannis DP, Roilides E, Zeller V, Taj-Aldeen SJ, Miller AO, Petraitiene R, Lortholary O, Walsh TJ. Candida Arthritis: Analysis of 112 Pediatric and Adult Cases. Open Forum Infect Dis. 2016 Jan; 3(1):ofv207. PMID: 26858961.
      View in: PubMed
    103. Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016 Feb 20; 387(10020):760-9. PMID: 26684607.
      View in: PubMed
    104. Ioannou P, Andrianaki A, Akoumianaki T, Kyrmizi I, Albert N, Perlin D, Samonis G, Kontoyiannis DP, Chamilos G. Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae. Antimicrob Agents Chemother. 2015 Dec 07; 60(3):1226-33. PMID: 26643329.
      View in: PubMed
    105. Taj-Aldeen SJ, Rammaert B, Gamaletsou M, Sipsas NV, Zeller V, Roilides E, Kontoyiannis DP, Miller AO, Petraitis V, Walsh TJ, Lortholary O. Osteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review. Medicine (Baltimore). 2015 Dec; 94(50):e2078. PMID: 26683917.
      View in: PubMed
    106. Aitken SL, Zhou J, Ghantoji SS, Kontoyiannis DP, Jones RB, Tam VH, Chemaly RF. Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients. J Antimicrob Chemother. 2016 Mar; 71(3):727-30. PMID: 26612873.
      View in: PubMed
    107. Shelburne SA, Ajami NJ, Chibucos MC, Beird HC, Tarrand J, Galloway-Peña J, Albert N, Chemaly RF, Ghantoji SS, Marsh L, Pemmaraju N, Andreeff M, Shpall EJ, Wargo JA, Rezvani K, Alousi A, Bruno VM, Futreal PA, Petrosino JF, Kontoyiannis DP. Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis. PLoS One. 2015; 10(11):e0139851. PMID: 26556047.
      View in: PubMed
    108. Jung DS, Farmakiotis D, Jiang Y, Tarrand JJ, Kontoyiannis DP. Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA. Emerg Infect Dis. 2015 Nov; 21(11):1942-50. PMID: 26488845.
      View in: PubMed
    109. Halpern AB, Lyman GH, Walsh TJ, Kontoyiannis DP, Walter RB. Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia. Blood. 2015 Dec 24; 126(26):2790-7. PMID: 26504183.
      View in: PubMed
    110. Shirazi F, Lewis RE, Kontoyiannis DP. Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin. Microb Cell. 2015 Oct 23; 2(11):445-450. PMID: 28357269.
      View in: PubMed
    111. Bellanger AP, Albert ND, Lewis RE, Walsh TJ, Kontoyiannis DP. Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae. Antimicrob Agents Chemother. 2015 Dec; 59(12):7830-2. PMID: 26392499.
      View in: PubMed
    112. Throckmorton K, Lim FY, Kontoyiannis DP, Zheng W, Keller NP. Redundant synthesis of a conidial polyketide by two distinct secondary metabolite clusters in Aspergillus fumigatus. Environ Microbiol. 2016 Jan; 18(1):246-59. PMID: 26242966.
      View in: PubMed
    113. Jung DS, Tverdek FP, Jiang Y, Kontoyiannis DP. Switching to anidulafungin from caspofungin in cancer patients in the setting of liver dysfunction is associated with improvement of liver function tests. J Antimicrob Chemother. 2015 Nov; 70(11):3100-6. PMID: 26311837.
      View in: PubMed
    114. Granwehr B, Kontoyiannis DP. The evolving landscape of gastrointestinal infections in neutropenic patients. Oncology (Williston Park). 2015 Aug; 29(8):590, 592-3. PMID: 26349340.
      View in: PubMed
    115. Davoudi S, Kumar VA, Jiang Y, Kupferman M, Kontoyiannis DP. Invasive mould sinusitis in patients with haematological malignancies: a 10 year single-centre study. J Antimicrob Chemother. 2015 Oct; 70(10):2899-905. PMID: 26188039.
      View in: PubMed
    116. Meller S, Di Domizio J, Voo KS, Friedrich HC, Chamilos G, Ganguly D, Conrad C, Gregorio J, Le Roy D, Roger T, Ladbury JE, Homey B, Watowich S, Modlin RL, Kontoyiannis DP, Liu YJ, Arold ST, Gilliet M. T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26. Nat Immunol. 2015 Sep; 16(9):970-9. PMID: 26168081.
      View in: PubMed
    117. Mircus G, Albert N, Ben-Yaakov D, Chikvashvili D, Shadkchan Y, Kontoyiannis DP, Osherov N. Identification and characterization of a novel family of selective antifungal compounds (CANBEFs) that interfere with fungal protein synthesis. Antimicrob Agents Chemother. 2015 Sep; 59(9):5631-40. PMID: 26149982.
      View in: PubMed
    118. Davoudi S, Graviss LS, Kontoyiannis DP. Healthcare-associated outbreaks due to Mucorales and other uncommon fungi. Eur J Clin Invest. 2015 Jul; 45(7):767-73. PMID: 25989947.
      View in: PubMed
    119. Neofytos D, Railkar R, Mullane KM, Fredricks DN, Granwehr B, Marr KA, Almyroudis NG, Kontoyiannis DP, Maertens J, Fox R, Douglas C, Iannone R, Kauh E, Shire N. Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis. PLoS One. 2015; 10(6):e0129022. PMID: 26107507.
      View in: PubMed
    120. Chitasombat MN, Kontoyiannis DP. The 'cephalosporin era' of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections. Expert Opin Pharmacother. 2015; 16(10):1543-58. PMID: 26100603.
      View in: PubMed
    121. Ananda-Rajah MR, Kontoyiannis D. Isavuconazole: a new extended spectrum triazole for invasive mold diseases. Future Microbiol. 2015; 10(5):693-708. PMID: 26000646.
      View in: PubMed
    122. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, Groeger JS, Judson MA, Vinagre YM, Heard SO, Zervou FN, Zacharioudakis IM, Kontoyiannis DP, Pappas PG. Reply to Bauer and Goff. Clin Infect Dis. 2015 Aug 01; 61(3):487-8. PMID: 25944341.
      View in: PubMed
    123. McCarty TP, Baddley JW, Walsh TJ, Alexander BD, Kontoyiannis DP, Perl TM, Walker R, Patterson TF, Schuster MG, Lyon GM, Wingard JR, Andes DR, Park BJ, Brandt ME, Pappas PG. Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET). Med Mycol. 2015 Jun; 53(5):440-6. PMID: 25908651.
      View in: PubMed
    124. Wang E, Farmakiotis D, Yang D, McCue DA, Kantarjian HM, Kontoyiannis DP, Mathisen MS. The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality. J Antimicrob Chemother. 2015 Aug; 70(8):2362-8. PMID: 25855759.
      View in: PubMed
    125. Zanette RA, Bitencourt PE, Kontoyiannis DP, Fighera RA, Flores MM, Kommers GD, Silva PS, Ludwig A, Moretto MB, Alves SH, Santurio JM. Complex interaction of deferasirox and Pythium insidiosum: iron-dependent attenuation of growth in vitro and immunotherapy-like enhancement of immune responses in vivo. PLoS One. 2015; 10(3):e0118932. PMID: 25738758.
      View in: PubMed
    126. Farmakiotis D, Kontoyiannis DP. Emerging issues with diagnosis and management of fungal infections in solid organ transplant recipients. Am J Transplant. 2015 May; 15(5):1141-7. PMID: 25655091.
      View in: PubMed
    127. Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, Heinz WJ, Jagannatha S, Koh LP, Kontoyiannis DP, Lee DG, Nucci M, Pappas PG, Slavin MA, Queiroz-Telles F, Selleslag D, Walsh TJ, Wingard JR, Maertens JA. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med. 2015 Jan 20; 162(2):81-9. PMID: 25599346.
      View in: PubMed
    128. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, Groeger JS, Judson MA, Vinagre YM, Heard SO, Zervou FN, Zacharioudakis IM, Kontoyiannis DP, Pappas PG. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015 Mar 15; 60(6):892-9. PMID: 25586686.
      View in: PubMed
    129. Torres HA, Mahale P, Blechacz B, Miller E, Kaseb A, Herlong HF, Fowler N, Jiang Y, Raad II, Kontoyiannis DP. Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Canc Netw. 2015 Jan; 13(1):41-50. PMID: 25583768.
      View in: PubMed
    130. Shirazi F, Kontoyiannis DP, Ibrahim AS. Iron starvation induces apoptosis in Rhizopus oryzae in vitro. Virulence. 2015; 6(2):121-6. PMID: 25830548.
      View in: PubMed
    131. Shirazi F, Kontoyiannis DP. Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates. Virulence. 2015; 6(4):385-94. PMID: 26065323.
      View in: PubMed
    132. Bellanger AP, Minetos YD, Albert N, Shirazi F, Walsh TJ, Kontoyiannis DP. Glucocorticosteroids do not impact directly growth rate and biomass of Rhizopus arrhizus (syn. R. oryzae) in vitro. Virulence. 2015; 6(5):441-3. PMID: 25942104.
      View in: PubMed
    133. Miller AO, Gamaletsou MN, Henry MW, Al-Hafez L, Hussain K, Sipsas NV, Kontoyiannis DP, Roilides E, Brause BD, Walsh TJ. Successful treatment of Candida osteoarticular infections with limited duration of antifungal therapy and orthopedic surgical intervention. Infect Dis (Lond). 2015 Mar; 47(3):144-9. PMID: 25539148.
      View in: PubMed
    134. Walsh TJ, Skiada A, Cornely OA, Roilides E, Ibrahim A, Zaoutis T, Groll A, Lortholary O, Kontoyiannis DP, Petrikkos G. Development of new strategies for early diagnosis of mucormycosis from bench to bedside. Mycoses. 2014 Dec; 57 Suppl 3:2-7. PMID: 25475924.
      View in: PubMed
    135. Kontoyiannis DP, Patterson TF. Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions. Clin Infect Dis. 2014 Nov 15; 59 Suppl 5:S356-9. PMID: 25352631.
      View in: PubMed
    136. Kontoyiannis DP, Lewis RE. Treatment principles for the management of mold infections. Cold Spring Harb Perspect Med. 2014 Nov 06; 5(4). PMID: 25377139.
      View in: PubMed
    137. Farmakiotis D, Tarrand JJ, Kontoyiannis DP. Drug-resistant Candida glabrata infection in cancer patients. Emerg Infect Dis. 2014 Nov; 20(11):1833-40. PMID: 25340258.
      View in: PubMed
    138. Raad II, Zakhem AE, Helou GE, Jiang Y, Kontoyiannis DP, Hachem R. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies. Int J Antimicrob Agents. 2015 Mar; 45(3):283-8. PMID: 25455847.
      View in: PubMed
    139. Farmakiotis D, Kyvernitakis A, Tarrand JJ, Kontoyiannis DP. Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation. Clin Microbiol Infect. 2015 Jan; 21(1):79-86. PMID: 25636931.
      View in: PubMed
    140. Askew DS, Kontoyiannis DP, Clemons KV. Advances against aspergillosis: biology, host response, diagnosis and treatment. Mycopathologia. 2014 Dec; 178(5-6):321-4. PMID: 25287755.
      View in: PubMed
    141. Shirazi F, Farmakiotis D, Yan Y, Albert N, Do KA, Kim-Anh D, Kontoyiannis DP. Diet modification and metformin have a beneficial effect in a fly model of obesity and mucormycosis. PLoS One. 2014; 9(9):e108635. PMID: 25268492.
      View in: PubMed
    142. Jung DS, Tverdek FP, Kontoyiannis DP. Switching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity. Antimicrob Agents Chemother. 2014 Nov; 58(11):6993-5. PMID: 25199774.
      View in: PubMed
    143. Lewis RE, Albert ND, Kontoyiannis DP. Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis. Antimicrob Agents Chemother. 2014 Nov; 58(11):6767-72. PMID: 25182639.
      View in: PubMed
    144. Zhao Y, Kontoyiannis DP, Roilides E, Walsh TJ, Perlin DS. Reply to "not over yet: fungal infections following methyl prednisolone injections smoulder on". J Clin Microbiol. 2014 Sep; 52(9):3508. PMID: 25143421.
      View in: PubMed
    145. Zhao Y, Kontoyiannis DP, Roilides E, Walsh TJ, Perlin DS. Reply to "detection of multiple fungal species in blood samples by real-time PCR: an interpretative challenge". J Clin Microbiol. 2014 Sep; 52(9):3517. PMID: 25143425.
      View in: PubMed
    146. Davoudi S, Anderlini P, Fuller GN, Kontoyiannis DP. A long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case. Mycopathologia. 2014 Dec; 178(5-6):465-70. PMID: 25086667.
      View in: PubMed
    147. Kontoyiannis DP, Lewis RE. Reply to "Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?". Antimicrob Agents Chemother. 2014 Aug; 58(8):4990-1. PMID: 25028731.
      View in: PubMed
    148. Simitsopoulou M, Walsh TJ, Kyrpitzi D, Petraitis V, Kontoyiannis DP, Perlin DS, Roilides E. Methylprednisolone impairs conidial phagocytosis but does not attenuate hyphal damage by neutrophils against Exserohilum rostratum. Med Mycol. 2015 Feb 01; 53(2):189-93. PMID: 25056961.
      View in: PubMed
    149. McCarthy M, Rosengart A, Schuetz AN, Kontoyiannis DP, Walsh TJ. Mold infections of the central nervous system. N Engl J Med. 2014 Jul 10; 371(2):150-60. PMID: 25006721.
      View in: PubMed
    150. Kumaresan PR, Manuri PR, Albert ND, Maiti S, Singh H, Mi T, Roszik J, Rabinovich B, Olivares S, Krishnamurthy J, Zhang L, Najjar AM, Huls MH, Lee DA, Champlin RE, Kontoyiannis DP, Cooper LJ. Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection. Proc Natl Acad Sci U S A. 2014 Jul 22; 111(29):10660-5. PMID: 25002471.
      View in: PubMed
    151. Rammaert B, Gamaletsou MN, Zeller V, Elie C, Prinapori R, Taj-Aldeen SJ, Roilides E, Kontoyiannis DP, Brause B, Sipsas NV, Walsh TJ, Lortholary O. Dimorphic fungal osteoarticular infections. Eur J Clin Microbiol Infect Dis. 2014 Dec; 33(12):2131-40. PMID: 24939620.
      View in: PubMed
    152. Shirazi F, Kontoyiannis DP. Heat shock protein 90 and calcineurin pathway inhibitors enhance the efficacy of triazoles against Scedosporium prolificans via induction of apoptosis. Microb Cell. 2014 Jun 02; 1(6):179-188. PMID: 28357242.
      View in: PubMed
    153. Jung DS, Kontoyiannis DP. Co-infection with Influenza: Do Not Forget Aspergillus in the Immunosuppressed Neutropenic Host. Tuberc Respir Dis (Seoul). 2014 May; 76(5):249. PMID: 24920954.
      View in: PubMed
    154. Farmakiotis D, Shirazi F, Zhao Y, Saad PJ, Albert ND, Roilides E, Walsh TJ, Perlin DS, Kontoyiannis DP. Methylprednisolone enhances the growth of Exserohilum rostratum in vitro, attenuates spontaneous apoptosis, and increases mortality rates in immunocompetent Drosophila flies. J Infect Dis. 2014 Nov 01; 210(9):1471-5. PMID: 24837401.
      View in: PubMed
    155. Thompson GR, Albert N, Hodge G, Wilson MD, Sykes JE, Bays DJ, Firacative C, Meyer W, Kontoyiannis DP. Phenotypic differences of Cryptococcus molecular types and their implications for virulence in a Drosophila model of infection. Infect Immun. 2014 Jul; 82(7):3058-65. PMID: 24799631.
      View in: PubMed
    156. Kontoyiannis DP, Mathur M, Chen YB, Shellito PC, Tse JY. Case records of the Massachusetts General Hospital. Case 13-2014. A 41-year-old man with fever and abdominal pain after stem-cell transplantation. N Engl J Med. 2014 Apr 24; 370(17):1637-46. PMID: 24758620.
      View in: PubMed
    157. Zhao Y, Armeanu E, DiVerniero R, Lewis TA, Dobson RC, Kontoyiannis DP, Roilides E, Walsh TJ, Perlin DS. Fungal DNA detected in blood samples of patients who received contaminated methylprednisolone injections reveals increased complexity of causative agents. J Clin Microbiol. 2014 Jun; 52(6):2212-5. PMID: 24719442.
      View in: PubMed
    158. Katragkou A, Pana ZD, Perlin DS, Kontoyiannis DP, Walsh TJ, Roilides E. Exserohilum infections: review of 48 cases before the 2012 United States outbreak. Med Mycol. 2014 May; 52(4):376-86. PMID: 24682112.
      View in: PubMed
    159. Pemmaraju N, Shetty AV, Prieto VG, Jain N, Kontoyiannis DP, Borthakur G. Disseminated Saprochaete capitata (formerly known as Geotrichum capitatum and Blastoschizomyces capitatus) in a patient with acute myeloid leukemia. Eur J Haematol. 2014 Dec; 93(6):543-4. PMID: 24592915.
      View in: PubMed
    160. Farmakiotis D, Tarrand JJ, Kontoyiannis DP. Efficacy and tolerability of micafungin monotherapy for candidemia and deep-seated candidiasis in adults with cancer. Antimicrob Agents Chemother. 2014 Jun; 58(6):3526-9. PMID: 24637687.
      View in: PubMed
    161. Gomes MZ, Jiang Y, Mulanovich VE, Lewis RE, Kontoyiannis DP. Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia. Antimicrob Agents Chemother. 2014 May; 58(5):2775-80. PMID: 24590477.
      View in: PubMed
    162. Kontoyiannis DP. Are respiratory complications more likely in patients with pulmonary aspergillosis treated with echinocandins in the setting of neutrophil influx? Virulence. 2014 Apr 01; 5(3):375-7. PMID: 24569451.
      View in: PubMed
    163. Ariza-Heredia EJ, Kontoyiannis DP. Our recommendations for avoiding exposure to fungi outside the hospital for patients with haematological cancers. Mycoses. 2014 Jun; 57(6):336-41. PMID: 24446760.
      View in: PubMed
    164. Lewis RE, Liao G, Young K, Douglas C, Kontoyiannis DP. Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungals. Antimicrob Agents Chemother. 2014; 58(3):1738-43. PMID: 24395226.
      View in: PubMed
    165. Gamaletsou MN, Rammaert B, Bueno MA, Moriyama B, Sipsas NV, Kontoyiannis DP, Roilides E, Zeller V, Prinapori R, Taj-Aldeen SJ, Brause B, Lortholary O, Walsh TJ. Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome. J Infect. 2014 May; 68(5):478-93. PMID: 24378282.
      View in: PubMed
    166. Ibrahim AS, Kontoyiannis DP. Update on mucormycosis pathogenesis. Curr Opin Infect Dis. 2013 Dec; 26(6):508-15. PMID: 24126718.
      View in: PubMed
    167. Gomes MZ, Mulanovich VE, Jiang Y, Lewis RE, Kontoyiannis DP. Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011. Antimicrob Agents Chemother. 2014; 58(2):865-73. PMID: 24277033.
      View in: PubMed
    168. Kontoyiannis DP, Azie N, Franks B, Horn DL. Prospective antifungal therapy (PATH) alliance(®) : focus on mucormycosis. Mycoses. 2014 Apr; 57(4):240-6. PMID: 24147728.
      View in: PubMed
    169. Dimopoulou D, Hamilos G, Tzardi M, Lewis RE, Samonis G, Kontoyiannis DP. Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibility. Antimicrob Agents Chemother. 2014; 58(1):229-36. PMID: 24145540.
      View in: PubMed
    170. Kontoyiannis DP. Rational approach to pulmonary infiltrates in leukemia and transplantation. Best Pract Res Clin Haematol. 2013 Sep; 26(3):301-6. PMID: 24309535.
      View in: PubMed
    171. Barbu EM, Shirazi F, McGrath DM, Albert N, Sidman RL, Pasqualini R, Arap W, Kontoyiannis DP. An antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosis. PLoS One. 2013; 8(10):e76981. PMID: 24098573.
      View in: PubMed
    172. Zanette RA, Santurio JM, Loreto ÉS, Alves SH, Kontoyiannis DP. Toll-deficient Drosophila is susceptible to Pythium insidiosum infection. Microbiol Immunol. 2013 Oct; 57(10):732-5. PMID: 23865688.
      View in: PubMed
    173. Lewis RE, Kontoyiannis DP. Epidemiology and treatment of mucormycosis. Future Microbiol. 2013 Sep; 8(9):1163-75. PMID: 24020743.
      View in: PubMed
    174. Xu-Monette ZY, Møller MB, Tzankov A, Montes-Moreno S, Hu W, Manyam GC, Kristensen L, Fan L, Visco C, Dybkaer K, Chiu A, Tam W, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huang Q, Huh J, Ai W, Ponzoni M, Ferreri AJ, Wu L, Zhao X, Bueso-Ramos CE, Wang SA, Go RS, Li Y, Winter JN, Piris MA, Medeiros LJ, Young KH. MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood. 2013 Oct 10; 122(15):2630-40. PMID: 22431807; PMCID: PMC3952598.
    175. Shirazi F, Kontoyiannis DP. The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosis. Eukaryot Cell. 2013 Sep; 12(9):1225-34. PMID: 23851337.
      View in: PubMed
    176. Kaluarachchi WD, Cisneros BT, Corr SJ, Albert ND, Curley SA, Kontoyiannis DP. Aspergillus fumigatus hyphal damage caused by noninvasive radiofrequency field-induced hyperthermia. Antimicrob Agents Chemother. 2013 Sep; 57(9):4444-8. PMID: 23836166.
      View in: PubMed
    177. Shirazi F, Pontikos MA, Walsh TJ, Albert N, Lewis RE, Kontoyiannis DP. Hyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action through apoptosis. Antimicrob Agents Chemother. 2013 Sep; 57(9):4360-8. PMID: 23817366.
      View in: PubMed
    178. Kyrmizi I, Gresnigt MS, Akoumianaki T, Samonis G, Sidiropoulos P, Boumpas D, Netea MG, van de Veerdonk FL, Kontoyiannis DP, Chamilos G. Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1/Syk kinase signaling. J Immunol. 2013 Aug 01; 191(3):1287-99. PMID: 23817424.
      View in: PubMed
    179. Granwehr BP, Kontoyiannis DP. The impact of infectious diseases consultation on oncology practice. Curr Opin Oncol. 2013 Jul; 25(4):353-9. PMID: 23736876.
      View in: PubMed
    180. Kontoyiannis DP. Virulence profile: Dimitrios P Kontoyiannis. Virulence. 2013 Jul 01; 4(5):429-31. PMID: 23799666.
      View in: PubMed
    181. Zanette RA, Kontoyiannis DP. Paradoxical effect to caspofungin in Candida species does not confer survival advantage in a Drosophila model of candidiasis. Virulence. 2013 Aug 15; 4(6):497-8. PMID: 23863608.
      View in: PubMed
    182. Thompson GR, Kontoyiannis DP, Patterson TF. Real-world experience in the midst of an Exserohilum meningitis outbreak. JAMA. 2013 Jun 19; 309(23):2493-5. PMID: 23780464.
      View in: PubMed
    183. Farmakiotis D, Ciurea AM, Cahuayme-Zuniga L, Kontoyiannis DP. The diagnostic yield of skin biopsy in patients with leukemia and suspected infection. J Infect. 2013 Oct; 67(4):265-72. PMID: 23769840.
      View in: PubMed
    184. Lewis RE, Georgiadou SP, Sampsonas F, Chamilos G, Kontoyiannis DP. Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis. Mycoses. 2014 Jan; 57(1):49-55. PMID: 23905713.
      View in: PubMed
    185. Shirazi F, Kontoyiannis DP. Mitochondrial respiratory pathways inhibition in Rhizopus oryzae potentiates activity of posaconazole and itraconazole via apoptosis. PLoS One. 2013; 8(5):e63393. PMID: 23696824.
      View in: PubMed
    186. Kontoyiannis DP, Perlin DS, Roilides E, Walsh TJ. What can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis? Clin Infect Dis. 2013 Sep; 57(6):853-9. PMID: 23650291.
      View in: PubMed
    187. Zanette RA, Kontoyiannis DP. Pre-exposure of Candida species to cytarabine and daunorubicin does not affect their in vitro antifungal susceptibility and virulence in flies. Virulence. 2013 May 15; 4(4):344-6. PMID: 23611830.
      View in: PubMed
    188. Berthier E, Lim FY, Deng Q, Guo CJ, Kontoyiannis DP, Wang CC, Rindy J, Beebe DJ, Huttenlocher A, Keller NP. Low-volume toolbox for the discovery of immunosuppressive fungal secondary metabolites. PLoS Pathog. 2013; 9(4):e1003289. PMID: 23592999.
      View in: PubMed
    189. Lewis RE, Cahyame-Zuniga L, Leventakos K, Chamilos G, Ben-Ami R, Tamboli P, Tarrand J, Bodey GP, Luna M, Kontoyiannis DP. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses. 2013 Nov; 56(6):638-45. PMID: 23551865.
      View in: PubMed
    190. Kontoyiannis DP. Preventing fungal disease in chronically immunosuppressed outpatients: time for action? Ann Intern Med. 2013 Apr 02; 158(7):555-6. PMID: 23546567.
      View in: PubMed
    191. Diaz L, Kontoyiannis DP, Panesso D, Albert ND, Singh KV, Tran TT, Munita JM, Murray BE, Arias CA. Dissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus. J Infect Dis. 2013 Jul; 208(1):83-91. PMID: 23547139.
      View in: PubMed
    192. Kontoyiannis DP, Georgiadou SP, Wierda WG, Wright S, Albert ND, Ferrajoli A, Keating M, Lewis RE. Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2013 Aug; 54(8):1730-3. PMID: 23163595.
      View in: PubMed
    193. Palmer JM, Bok JW, Lee S, Dagenais TRT, Andes DR, Kontoyiannis DP, Keller NP. Loss of CclA, required for histone 3 lysine 4 methylation, decreases growth but increases secondary metabolite production in Aspergillus fumigatus. PeerJ. 2013; 1:e4. PMID: 23638376.
      View in: PubMed
    194. Pappas PG, Kontoyiannis DP, Perfect JR, Chiller TM. Real-time treatment guidelines: considerations during the Exserohilum rostratum outbreak in the United States. Antimicrob Agents Chemother. 2013 Apr; 57(4):1573-6. PMID: 23384532.
      View in: PubMed
    195. Lewis RE, Albert NP, Liao G, Wang W, Prince RA, Kontoyiannis DP. High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia. J Antimicrob Chemother. 2013 May; 68(5):1148-51. PMID: 23349440.
      View in: PubMed
    196. McGrath DM, Barbu EM, Driessen WH, Lasco TM, Tarrand JJ, Okhuysen PC, Kontoyiannis DP, Sidman RL, Pasqualini R, Arap W. Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic. Proc Natl Acad Sci U S A. 2013 Feb 26; 110(9):3477-82. PMID: 23345420.
      View in: PubMed
    197. Ben-Ami R, Albert ND, Lewis RE, Kontoyiannis DP. Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis. J Infect Dis. 2013 Apr; 207(7):1066-74. PMID: 23303813.
      View in: PubMed
    198. Lewis RE, Ben-Ami R, Best L, Albert N, Walsh TJ, Kontoyiannis DP. Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis. J Infect Dis. 2013 Mar 01; 207(5):834-41. PMID: 23242544.
      View in: PubMed
    199. Ben-Ami R, Watson CC, Lewis RE, Albert ND, Arias CA, Raad II, Kontoyiannis DP. Drosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment. Microb Pathog. 2013 Feb; 55:16-20. PMID: 23232438.
      View in: PubMed
    200. Georgiadou SP, Kontoyiannis DP. The impact of azole resistance on aspergillosis guidelines. Ann N Y Acad Sci. 2012 Dec; 1272:15-22. PMID: 23231710.
      View in: PubMed
    201. Georgiadou SP, Tarrand J, Sipsas NV, Kontoyiannis DP. Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker? Mycoses. 2013 May; 56(3):311-4. PMID: 23170870.
      View in: PubMed
    202. Farmakiotis D, Tverdek FP, Kontoyiannis DP. The safety of amphotericin B lipid complex in patients with prior severe intolerance to liposomal amphotericin B. Clin Infect Dis. 2013 Mar; 56(5):701-3. PMID: 23166189.
      View in: PubMed
    203. Ben-Ami R, Rahav G, Elinav H, Kassis I, Shalit I, Gottesman T, Megged O, Weinberger M, Ciobotaro P, Shitrit P, Weber G, Paz A, Miron D, Oren I, Bishara J, Block C, Keller N, Kontoyiannis DP, Giladi M. Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel. Clin Microbiol Infect. 2013 Aug; 19(8):752-6. PMID: 23005038.
      View in: PubMed
    204. Gamaletsou MN, Sipsas NV, Kontoyiannis DP, Tsiakalos A, Kontos AN, Stefanou I, Kordossis T. Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-?. Diagn Microbiol Infect Dis. 2012 Dec; 74(4):409-11. PMID: 22975207.
      View in: PubMed
    205. Chamilos G, Gregorio J, Meller S, Lande R, Kontoyiannis DP, Modlin RL, Gilliet M. Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37. Blood. 2012 Nov 01; 120(18):3699-707. PMID: 22927244.
      View in: PubMed
    206. Gamaletsou MN, Kontoyiannis DP, Sipsas NV, Moriyama B, Alexander E, Roilides E, Brause B, Walsh TJ. Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011). Clin Infect Dis. 2012 Nov 15; 55(10):1338-51. PMID: 22911646.
      View in: PubMed
    207. Georgiadou SP, Sampsonas FL, Rice D, Granger JM, Swisher S, Kontoyiannis DP. Open-lung biopsy in patients with undiagnosed lung lesions referred at a tertiary cancer center is safe and reveals noncancerous, noninfectious entities as the most common diagnoses. Eur J Clin Microbiol Infect Dis. 2013 Jan; 32(1):101-5. PMID: 22895891.
      View in: PubMed
    208. Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HA. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012 Dec; 57(6):1177-85. PMID: 22871500.
      View in: PubMed
    209. Lewis RE, Viale P, Kontoyiannis DP. The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida. Virulence. 2012 Jul 01; 3(4):368-76. PMID: 22722245.
      View in: PubMed
    210. Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, Schuster MG, Brizendine KD, Patterson TF, Lyon GM, Boeckh M, Oster RA, Chiller T, Pappas PG. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Med Mycol. 2013 Feb; 51(2):128-35. PMID: 22680976.
      View in: PubMed
    211. Petraitis V, Petraitiene R, Antachopoulos C, Hughes JE, Cotton MP, Kasai M, Harrington S, Gamaletsou MN, Bacher JD, Kontoyiannis DP, Roilides E, Walsh TJ. Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism. Med Mycol. 2013 Jan; 51(1):72-82. PMID: 22686246.
      View in: PubMed
    212. Georgiadou SP, Lewis RE, Best L, Torres HA, Champlin RE, Kontoyiannis DP. The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis. Bone Marrow Transplant. 2013 Jan; 48(1):141-3. PMID: 22635244.
      View in: PubMed
    213. Georgiadou SP, Kontoyiannis DP. Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: how firm is the Aspergillus diagnosis? J Infect. 2012 Sep; 65(3):262-8. PMID: 22580034.
      View in: PubMed
    214. Georgiadou SP, Pongas G, Fitzgerald NE, Lewis RE, Rytting M, Marom EM, Kontoyiannis DP. Invasive Mold Infections in Pediatric Cancer Patients Reflect Heterogeneity in Etiology, Presentation, and Outcome: A 10-Year, Single-Institution, Retrospective Study. J Pediatric Infect Dis Soc. 2012 Jun; 1(2):125-35. PMID: 26619165.
      View in: PubMed
    215. Muhammed M, Feldmesser M, Shubitz LF, Lionakis MS, Sil A, Wang Y, Glavis-Bloom J, Lewis RE, Galgiani JN, Casadevall A, Kontoyiannis DP, Mylonakis E. Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus. Virulence. 2012 May 01; 3(3):329-38. PMID: 22546902.
      View in: PubMed
    216. Torres HA, Nevah MI, Barnett BJ, Mahale P, Kontoyiannis DP, Hassan MM, Raad II. Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: a retrospective multicenter study. J Clin Virol. 2012 Jul; 54(3):218-22. PMID: 22459004.
      View in: PubMed
    217. Spellberg B, Kontoyiannis DP, Fredricks D, Morris MI, Perfect JR, Chin-Hong PV, Ibrahim AS, Brass EP. Risk factors for mortality in patients with mucormycosis. Med Mycol. 2012 Aug; 50(6):611-8. PMID: 22435877.
      View in: PubMed
    218. Tarrand JJ, LaSala PR, Han XY, Rolston KV, Kontoyiannis DP. Dimethyl sulfoxide enhances effectiveness of skin antiseptics and reduces contamination rates of blood cultures. J Clin Microbiol. 2012 May; 50(5):1552-7. PMID: 22378911.
      View in: PubMed
    219. Hamilos G, Samonis G, Kontoyiannis DP. Recent Advances in the Use of Drosophila melanogaster as a Model to Study Immunopathogenesis of Medically Important Filamentous Fungi. Int J Microbiol. 2012; 2012:583792. PMID: 22518146.
      View in: PubMed
    220. Sipsas NV, Kontoyiannis DP. Invasive fungal infections in patients with cancer in the Intensive Care Unit. Int J Antimicrob Agents. 2012 Jun; 39(6):464-71. PMID: 22337064.
      View in: PubMed
    221. Ben-Ami R, Olshtain-Pops K, Krieger M, Oren I, Bishara J, Dan M, Wiener-Well Y, Weinberger M, Zimhony O, Chowers M, Weber G, Potasman I, Chazan B, Kassis I, Shalit I, Block C, Keller N, Kontoyiannis DP, Giladi M. Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrob Agents Chemother. 2012 May; 56(5):2518-23. PMID: 22314534.
      View in: PubMed
    222. Lewis RE, Lortholary O, Spellberg B, Roilides E, Kontoyiannis DP, Walsh TJ. How does antifungal pharmacology differ for mucormycosis versus aspergillosis? Clin Infect Dis. 2012 Feb; 54 Suppl 1:S67-72. PMID: 22247448.
      View in: PubMed
    223. Spellberg B, Ibrahim A, Roilides E, Lewis RE, Lortholary O, Petrikkos G, Kontoyiannis DP, Walsh TJ. Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis. 2012 Feb; 54 Suppl 1:S73-8. PMID: 22247449.
      View in: PubMed
    224. Kontoyiannis DP, Lewis RE, Lortholary O, Lotholary O, Spellberg B, Petrikkos G, Roilides E, Roillides E, Ibrahim A, Walsh TJ. Future directions in mucormycosis research. Clin Infect Dis. 2012 Feb; 54 Suppl 1:S79-85. PMID: 22247450.
      View in: PubMed
    225. Walsh TJ, Bloom BE, Kontoyiannis DP. Meeting the challenges of an emerging pathogen: the Henry Schueler 41&9 Foundation International Forum on Mucormycosis. Clin Infect Dis. 2012 Feb; 54 Suppl 1:S1-4. PMID: 22247440.
      View in: PubMed
    226. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012 Feb; 54 Suppl 1:S16-22. PMID: 22247441.
      View in: PubMed
    227. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012 Feb; 54 Suppl 1:S23-34. PMID: 22247442.
      View in: PubMed
    228. Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012 Feb; 54 Suppl 1:S55-60. PMID: 22247446.
      View in: PubMed
    229. Roilides E, Kontoyiannis DP, Walsh TJ. Host defenses against zygomycetes. Clin Infect Dis. 2012 Feb; 54 Suppl 1:S61-6. PMID: 22247447.
      View in: PubMed
    230. Kontoyiannis DP. Invasive mycoses: strategies for effective management. Am J Med. 2012 Jan; 125(1 Suppl):S25-38. PMID: 22196206.
      View in: PubMed
    231. Ben-Ami R, Kontoyiannis DP. Resistance to echinocandins comes at a cost: the impact of FKS1 hotspot mutations on Candida albicans fitness and virulence. Virulence. 2012 Jan-Feb; 3(1):95-7. PMID: 22286697.
      View in: PubMed
    232. Lionakis MS, Kontoyiannis DP. Drosophila melanogaster as a model organism for invasive aspergillosis. Methods Mol Biol. 2012; 845:455-68. PMID: 22328395.
      View in: PubMed
    233. Ben-Ami R, Kontoyiannis DP. A nonlethal murine cutaneous model of invasive aspergillosis. Methods Mol Biol. 2012; 845:569-82. PMID: 22328405.
      View in: PubMed
    234. Hamilos G, Samonis G, Kontoyiannis DP. Pulmonary mucormycosis. Semin Respir Crit Care Med. 2011 Dec; 32(6):693-702. PMID: 22167397.
      View in: PubMed
    235. Kontoyiannis DP. A clinical approach to assess treatment for presumed and documented invasive mold infections in patients with hematologic malignancies: focus on Spanish Society of Chemotherapy Guidelines. Rev Esp Quimioter. 2011 Dec; 24(4):173-4. PMID: 22173185.
      View in: PubMed
    236. Cahuayme-Zuniga L, Lewis RE, Mulanovich VE, Kontoyiannis DP. Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies. Med Mycol. 2012 Jul; 50(5):543-8. PMID: 22103347.
      View in: PubMed
    237. Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. J Infect. 2012 Jan; 64(1):68-75. PMID: 22101079.
      View in: PubMed
    238. Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt L, Ito JI, Kauffman CA, Lyon GM, Marr KA, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wingard JR, Walsh TJ, Kontoyiannis DP. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis. 2011 Oct; 17(10):1855-64. PMID: 22000355.
      View in: PubMed
    239. Perfect JR, Pfaller MA, Ostrosky-Zeichner L, Kontoyiannis DP. Invasive mycoses: evolving challenges and opportunities in antifungal therapy (multimedia activity). Am J Med. 2011 Oct; 124(10):S2-3. PMID: 21962326.
      View in: PubMed
    240. Kontoyiannis DP. The power of a legend. Ann Intern Med. 2011 Sep 20; 155(6):400. PMID: 21930861.
      View in: PubMed
    241. Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EP. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother. 2012 Mar; 67(3):715-22. PMID: 21937481.
      View in: PubMed
    242. Al Akhrass F, Hachem R, Mohamed JA, Tarrand J, Kontoyiannis DP, Chandra J, Ghannoum M, Haydoura S, Chaftari AM, Raad I. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis. 2011 Sep; 17(9):1651-8. PMID: 21888790.
      View in: PubMed
    243. Ben-Ami R, Garcia-Effron G, Lewis RE, Gamarra S, Leventakos K, Perlin DS, Kontoyiannis DP. Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance. J Infect Dis. 2011 Aug 15; 204(4):626-35. PMID: 21791665.
      View in: PubMed
    244. Marom EM, Kontoyiannis DP. Imaging studies for diagnosing invasive fungal pneumonia in immunocompromised patients. Curr Opin Infect Dis. 2011 Aug; 24(4):309-14. PMID: 21673574.
      View in: PubMed
    245. Mulanovich VE, Kontoyiannis DP. Fungal pneumonia in patients with hematologic malignancies: current approach and management. Curr Opin Infect Dis. 2011 Aug; 24(4):323-32. PMID: 21666457.
      View in: PubMed
    246. Chen SC, Lewis RE, Kontoyiannis DP. Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species. Virulence. 2011 Jul-Aug; 2(4):280-95. PMID: 21701255.
      View in: PubMed
    247. Lewis RE, Liao G, Wang W, Prince RA, Kontoyiannis DP. Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection. Virulence. 2011 Jul-Aug; 2(4):348-55. PMID: 21788730.
      View in: PubMed
    248. Lockhart SR, Zimbeck AJ, Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Pappas PG, Chiller T. In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrob Agents Chemother. 2011 Aug; 55(8):3944-6. PMID: 21670187.
      View in: PubMed
    249. Ramos ER, Jiang Y, Hachem R, Kassis C, Kontoyiannis DP, Raad I. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist. 2011; 16(7):1049-60. PMID: 21659609.
      View in: PubMed
    250. Kontoyiannis DP, Lewis RE. How I treat mucormycosis. Blood. 2011 Aug 04; 118(5):1216-24. PMID: 21622653.
      View in: PubMed
    251. Terzis ID, Papamichail C, Psaltopoulou T, Georgiopoulos GA, Lipsou N, Chatzidou S, Kontoyiannis D, Kollias G, Iacovidou N, Zakopoulos N, Alevizaki M, Stamatelopoulos KS. Long-Term BMI changes since adolescence and markers of early and advanced subclinical atherosclerosis. Obesity (Silver Spring). 2012 Feb; 20(2):414-20. PMID: 21617635.
      View in: PubMed
    252. Kontoyiannis DP. Are serum cytokines sensitive and specific enough to prognosticate in aspergillosis? J Infect Dis. 2011 May 15; 203(10):1503; author reply 1504. PMID: 21502086.
      View in: PubMed
    253. Lewis RE, Leventakos K, Liao G, Kontoyiannis DP. Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis. Antimicrob Agents Chemother. 2011 Jul; 55(7):3584-7. PMID: 21537029.
      View in: PubMed
    254. Kontoyiannis DP. Deferasirox lacks in vitro activity against Fusarium and Scedosporium species and black molds. Virulence. 2011 May-Jun; 2(3):257-8. PMID: 21543881.
      View in: PubMed
    255. Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis. 2011 May; 52(9):1144-55. PMID: 21467021.
      View in: PubMed
    256. Lewis RE, Liao G, Hou J, Prince RA, Kontoyiannis DP. Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus. J Antimicrob Chemother. 2011 Jun; 66(6):1324-31. PMID: 21486855.
      View in: PubMed
    257. Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev. 2011 Apr; 24(2):411-45. PMID: 21482731.
      View in: PubMed
    258. Rizos EC, Salanti G, Kontoyiannis DP, Ioannidis JP. Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents. J Clin Epidemiol. 2011 Aug; 64(8):830-42. PMID: 21411286.
      View in: PubMed
    259. Khan H, Oberoi S, Mahvash A, Sharma M, Rondon G, Alousi A, Shpall EJ, Kontoyiannis DP, Champlin RE, Ciurea SO. Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement. Biol Blood Marrow Transplant. 2011 Oct; 17(10):1551-5. PMID: 21396475.
      View in: PubMed
    260. Person AK, Kontoyiannis DP, Alexander BD. Fungal infections in transplant and oncology patients. Hematol Oncol Clin North Am. 2011 Feb; 25(1):193-213. PMID: 21236398.
      View in: PubMed
    261. Sampsonas F, Kontoyiannis DP, Dickey BF, Evans SE. Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study. Cancer. 2011 Aug 01; 117(15):3424-33. PMID: 21246537.
      View in: PubMed
    262. Chamilos G, Samonis G, Kontoyiannis DP. Drosophila melanogaster as a model host for the study of microbial pathogenicity and the discovery of novel antimicrobial compounds. Curr Pharm Des. 2011; 17(13):1246-53. PMID: 21470115.
      View in: PubMed
    263. Pongas G, Hamilos G, Rolston KV, Kontoyiannis DP. Formal adult infectious disease specialist consultations in the outpatient setting at a comprehensive cancer center (1998-2008): diverse and impactful. Support Care Cancer. 2012 Feb; 20(2):261-5. PMID: 21191800.
      View in: PubMed
    264. Chen SC, Kontoyiannis DP. New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients. Curr Opin Infect Dis. 2010 Dec; 23(6):567-77. PMID: 20827189.
      View in: PubMed
    265. Al Akhrass F, Debiane L, Abdallah L, Best L, Mulanovich V, Rolston K, Kontoyiannis DP. Palatal mucormycosis in patients with hematologic malignancy and stem cell transplantation. Med Mycol. 2011 May; 49(4):400-5. PMID: 21077735.
      View in: PubMed
    266. Kontoyiannis DP. Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success. Bone Marrow Transplant. 2011 Feb; 46(2):165-73. PMID: 21042306.
      View in: PubMed
    267. Lionakis MS, Kontoyiannis DP. The growing promise of Toll-deficient Drosophila melanogaster as a model for studying Aspergillus pathogenesis and treatment. Virulence. 2010 Nov-Dec; 1(6):488-99. PMID: 21178494.
      View in: PubMed
    268. Evans SE, Leventakos K, Ben-Ami R, You D, Thakkar SG, Lewis RE, Kontoyiannis DP. Toll-deficient Drosophila are resistant to infection by Pneumocystis spp.: additional evidence of specificity to mammalian hosts. Virulence. 2010 Nov-Dec; 1(6):523-5. PMID: 21178507.
      View in: PubMed
    269. Ben-Ami R, Lewis RE, Kontoyiannis DP. In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods. Med Mycol. 2011 Apr; 49(3):285-8. PMID: 21028945.
      View in: PubMed
    270. Lewis RE, Pongas GN, Albert N, Ben-Ami R, Walsh TJ, Kontoyiannis DP. Activity of deferasirox in Mucorales: influences of species and exogenous iron. Antimicrob Agents Chemother. 2011 Jan; 55(1):411-3. PMID: 20956598.
      View in: PubMed
    271. Chamilos G, Ganguly D, Lande R, Gregorio J, Meller S, Goldman WE, Gilliet M, Kontoyiannis DP. Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses. PLoS One. 2010 Sep 23; 5(9):e12955. PMID: 20886035.
      View in: PubMed
    272. Feldman EM, Kontoyiannis DP, Sharabi SE, Lee E, Kaufman Y, Heller L. Breast implant infections: is cefazolin enough? Plast Reconstr Surg. 2010 Sep; 126(3):779-85. PMID: 20811212.
      View in: PubMed
    273. Milito MA, Kontoyiannis DP, Lewis RE, Liu P, Mawlawi OR, Truong MT, Marom EM. Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis. Med Mycol. 2010 Sep; 48(6):817-23. PMID: 20109093.
      View in: PubMed
    274. Nguyen MH, Husain S, Clancy CJ, Peacock JE, Hung CC, Kontoyiannis DP, Morris AJ, Heath CH, Wagener M, Yu VL. Outcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study. J Infect. 2010 Nov; 61(5):419-26. PMID: 20732350.
      View in: PubMed
    275. Tsatsanis C, Margioris AN, Kontoyiannis DP. Association between H1N1 infection severity and obesity-adiponectin as a potential etiologic factor. J Infect Dis. 2010 Aug 15; 202(3):459-60. PMID: 20557238.
      View in: PubMed
    276. Ben-Ami R, Lewis RE, Kontoyiannis DP. Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. Br J Haematol. 2010 Aug; 150(4):406-17. PMID: 20618330.
      View in: PubMed
    277. Safdar A, Ma J, Saliba F, Dupont B, Wingard JR, Hachem RY, Mattiuzzi GN, Chandrasekar PH, Kontoyiannis DP, Rolston KV, Walsh TJ, Champlin RE, Raad II. Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis. Medicine (Baltimore). 2010 Jul; 89(4):236-44. PMID: 20616663.
      View in: PubMed
    278. Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, Oster RA, Anaissie EJ, Walsh TJ, Schuster MG, Wingard JR, Patterson TF, Ito JI, Williams OD, Chiller T, Pappas PG. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis. 2010 Jun 15; 50(12):1559-67. PMID: 20450350.
      View in: PubMed
    279. Panackal AA, Li H, Kontoyiannis DP, Mori M, Perego CA, Boeckh M, Marr KA. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin Infect Dis. 2010 Jun 15; 50(12):1588-97. PMID: 20450414.
      View in: PubMed
    280. Cahuayme-Zuniga L, Kontoyiannis DP. Is it safe to proceed with stem cell transplant in cancer patients treated for cryptococcal infection? A focus on recent IDSA cryptococcal guidelines. Clin Infect Dis. 2010 Jun 15; 50(12):1687-9. PMID: 20482268.
      View in: PubMed
    281. Person AK, Kontoyiannis DP, Alexander BD. Fungal infections in transplant and oncology patients. Infect Dis Clin North Am. 2010 Jun; 24(2):439-59. PMID: 20466278.
      View in: PubMed
    282. Mulanovich VE, Ahmed SI, Öztürk T, Khokhar FA, Kontoyiannis DP, de Lima M. Toxoplasmosis in allo-SCT patients: risk factors and outcomes at a transplantation center with a low incidence. Bone Marrow Transplant. 2011 Feb; 46(2):273-7. PMID: 20436521.
      View in: PubMed
    283. Chamilos G, Bignell EM, Schrettl M, Lewis RE, Leventakos K, May GS, Haas H, Kontoyiannis DP. Exploring the concordance of Aspergillus fumigatus pathogenicity in mice and Toll-deficient flies. Med Mycol. 2010 May; 48(3):506-10. PMID: 20370364.
      View in: PubMed
    284. Kontoyiannis DP. Manipulation of host angioneogenesis: A critical link for understanding the pathogenesis of invasive mold infections? Virulence. 2010 May-Jun; 1(3):192-6. PMID: 21178441.
      View in: PubMed
    285. Ben-Ami R, Varga V, Lewis RE, May GS, Nierman WC, Kontoyiannis DP. Characterization of a 5-azacytidine-induced developmental Aspergillus fumigatus variant. Virulence. 2010 May-Jun; 1(3):164-73. PMID: 21178435.
      View in: PubMed
    286. Oxman DA, Chow JK, Frendl G, Hadley S, Hershkovitz S, Ireland P, McDermott LA, Tsai K, Marty FM, Kontoyiannis DP, Golan Y. Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern? J Antimicrob Chemother. 2010 Jul; 65(7):1460-5. PMID: 20430790.
      View in: PubMed
    287. Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, Kontoyiannis DP, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Perl TM, Oster RA, Schuster MG, Walker R, Walsh TJ, Wannemuehler KA, Chiller TM. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010 Apr 15; 50(8):1101-11. PMID: 20218876.
      View in: PubMed
    288. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010 Apr 15; 50(8):1091-100. PMID: 20218877.
      View in: PubMed
    289. Ben-Ami R, Lamaris GA, Lewis RE, Kontoyiannis DP. Interstrain variability in the virulence of Aspergillus fumigatus and Aspergillus terreus in a Toll-deficient Drosophila fly model of invasive aspergillosis. Med Mycol. 2010 Mar; 48(2):310-7. PMID: 19642052.
      View in: PubMed
    290. Tan CH, Kontoyiannis DP, Viswanathan C, Iyer RB. Tuberculosis: a benign impostor. AJR Am J Roentgenol. 2010 Mar; 194(3):555-61. PMID: 20173128.
      View in: PubMed
    291. Ben-Ami R, Lewis RE, Leventakos K, Latgé JP, Kontoyiannis DP. Cutaneous model of invasive aspergillosis. Antimicrob Agents Chemother. 2010 May; 54(5):1848-54. PMID: 20145078.
      View in: PubMed
    292. Campo M, Lewis RE, Kontoyiannis DP. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. J Infect. 2010 May; 60(5):331-7. PMID: 20138081.
      View in: PubMed
    293. Leventakos K, Lewis RE, Kontoyiannis DP. Fungal infections in leukemia patients: how do we prevent and treat them? Clin Infect Dis. 2010 Feb 01; 50(3):405-15. PMID: 20047485.
      View in: PubMed
    294. Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, Dupont HL, Adachi JA. Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis. 2010 Feb 01; 50(3):374-80. PMID: 20038242.
      View in: PubMed
    295. Ben-Ami R, Lasala PR, Lewis RE, Kontoyiannis DP. Lack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosis. Diagn Microbiol Infect Dis. 2010 Feb; 66(2):200-3. PMID: 19836185.
      View in: PubMed
    296. Lewis RE, Albert ND, Liao G, Hou J, Prince RA, Kontoyiannis DP. Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis. Antimicrob Agents Chemother. 2010 Mar; 54(3):1298-304. PMID: 20038620.
      View in: PubMed
    297. Kofteridis DP, Lewis RE, Kontoyiannis DP. Caspofungin-non-susceptible Candida isolates in cancer patients. J Antimicrob Chemother. 2010 Feb; 65(2):293-5. PMID: 20016020.
      View in: PubMed
    298. Ben-Ami R, Lewis RE, Tarrand J, Leventakos K, Kontoyiannis DP. Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection. Antimicrob Agents Chemother. 2010 Jan; 54(1):484-90. PMID: 19858263.
      View in: PubMed
    299. Ben-Ami R, Lewis RE, Leventakos K, Kontoyiannis DP. Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites. Blood. 2009 Dec 17; 114(26):5393-9. PMID: 19843884.
      View in: PubMed
    300. Sipsas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, Raad II, Kontoyiannis DP. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer. 2009 Oct 15; 115(20):4745-52. PMID: 19634156.
      View in: PubMed
    301. Ravandi F, Aribi A, O'Brien S, Faderl S, Jones D, Ferrajoli A, Huang X, York S, Pierce S, Wierda W, Kontoyiannis D, Verstovsek S, Pro B, Fayad L, Keating M, Kantarjian H. Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms. J Clin Oncol. 2009 Nov 10; 27(32):5425-30. PMID: 19805674.
      View in: PubMed
    302. Pongas GN, Lewis RE, Samonis G, Kontoyiannis DP. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? Clin Microbiol Infect. 2009 Oct; 15 Suppl 5:93-7. PMID: 19754766.
      View in: PubMed
    303. Granger JM, Kontoyiannis DP. Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study. Cancer. 2009 Sep 01; 115(17):3919-23. PMID: 19551882.
      View in: PubMed
    304. Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Balajee SA, Pappas PG, Moser SA. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol. 2009 Oct; 47(10):3271-5. PMID: 19692558.
      View in: PubMed
    305. Shannon VR, Andersson BS, Lei X, Champlin RE, Kontoyiannis DP. Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010 Apr; 45(4):647-55. PMID: 19684637.
      View in: PubMed
    306. Kontoyiannis DP. Echinocandin-based initial therapy in fungemic patients with cancer: a focus on recent guidelines of the infectious diseases society of america. Clin Infect Dis. 2009 Aug 15; 49(4):638-9; author reply 639-40. PMID: 19619044.
      View in: PubMed
    307. Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, Andes D, Kontoyiannis DP, Perrone G, Peterson S, Brandt ME, Pappas PG, Chiller T. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol. 2009 Oct; 47(10):3138-41. PMID: 19675215.
      View in: PubMed
    308. Ben-Ami R, Lewis RE, Kontoyiannis DP. Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challenges. Curr Opin Infect Dis. 2009 Aug; 22(4):376-84. PMID: 19491674.
      View in: PubMed
    309. Pongas GN, Ben-Ami R, Lewis RE, Walsh TJ, Kontoyiannis DP. Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosis. Antimicrob Agents Chemother. 2009 Oct; 53(10):4569. PMID: 19635953.
      View in: PubMed
    310. Nedel WL, Kontoyiannis DP, Pasqualotto AC. Aspergillosis in patients treated with monoclonal antibodies. Rev Iberoam Micol. 2009 Sep 30; 26(3):175-83. PMID: 19635439.
      View in: PubMed
    311. Chamilos G, Nobile CJ, Bruno VM, Lewis RE, Mitchell AP, Kontoyiannis DP. Candida albicans Cas5, a regulator of cell wall integrity, is required for virulence in murine and toll mutant fly models. J Infect Dis. 2009 Jul 01; 200(1):152-7. PMID: 19463063.
      View in: PubMed
    312. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009 Jun 15; 48(12):1743-51. PMID: 19435437.
      View in: PubMed
    313. Ben-Ami R, Luna M, Lewis RE, Walsh TJ, Kontoyiannis DP. A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response. J Infect. 2009 Aug; 59(2):134-8. PMID: 19576639.
      View in: PubMed
    314. Lamaris GA, Ben-Ami R, Lewis RE, Chamilos G, Samonis G, Kontoyiannis DP. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. J Infect Dis. 2009 May 01; 199(9):1399-406. PMID: 19358672.
      View in: PubMed
    315. Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP. Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis. 2009 Apr 15; 48(8):1033-41. PMID: 19267655.
      View in: PubMed
    316. Yang Z, Kontoyiannis DP, Wen X, Xiong C, Zhang R, Albert ND, Li C. Gamma scintigraphy imaging of murine invasive pulmonary aspergillosis with a (111)In-labeled cyclic peptide. Nucl Med Biol. 2009 Apr; 36(3):259-66. PMID: 19324271.
      View in: PubMed
    317. Evans SE, Scott BL, Clement CG, Larson DT, Kontoyiannis D, Lewis RE, Lasala PR, Pawlik J, Peterson JW, Chopra AK, Klimpel G, Bowden G, Höök M, Xu Y, Tuvim MJ, Dickey BF. Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Am J Respir Cell Mol Biol. 2010 Jan; 42(1):40-50. PMID: 19329554.
      View in: PubMed
    318. Sipsas NV, Lewis RE, Raad II, Kontoyiannis DP. Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study. Int J Antimicrob Agents. 2009 Jul; 34(1):95-8. PMID: 19251404.
      View in: PubMed
    319. Roussos P, Lewis RE, Kontoyiannis DP. Azoles and antidepressants: a mini-review of the tolerability of co-administration. Mycoses. 2009 Sep; 52(5):433-9. PMID: 19207836.
      View in: PubMed
    320. Kontoyiannis DP, Lewis RE, Marr K. The burden of bacterial and viral infections in hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2009 Jan; 15(1 Suppl):128-33. PMID: 19147091.
      View in: PubMed
    321. Qiao J, Kontoyiannis DP, Calderone R, Li D, Ma Y, Wan Z, Li R, Liu W. Afyap1, encoding a bZip transcriptional factor of Aspergillus fumigatus, contributes to oxidative stress response but is not essential to the virulence of this pathogen in mice immunosuppressed by cyclophosphamide and triamcinolone. Med Mycol. 2008 Dec; 46(8):773-82. PMID: 18608886.
      View in: PubMed
    322. Torres HA, Aguilera E, Safdar A, Rohatgi N, Raad II, Sepulveda C, Luna M, Kontoyiannis DP, Chemaly RF. Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case-control study. Clin Microbiol Infect. 2008 Dec; 14(12):1160-6. PMID: 19046167.
      View in: PubMed
    323. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol. 2009 Jan; 47(1):129-33. PMID: 19005145.
      View in: PubMed
    324. Sipsas NV, Kontoyiannis DP. Occupation, lifestyle, diet, and invasive fungal infections. Infection. 2008 Dec; 36(6):515-25. PMID: 18998051.
      View in: PubMed
    325. Kontoyiannis DP, Ratanatharathorn V, Young JA, Raymond J, Laverdière M, Denning DW, Patterson TF, Facklam D, Kovanda L, Arnold L, Lau W, Buell D, Marr KA. Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis. Transpl Infect Dis. 2009 Feb; 11(1):89-93. PMID: 18983417.
      View in: PubMed
    326. Ibrahim AS, Gebremariam T, Liu M, Chamilos G, Kontoyiannis D, Mink R, Kwon-Chung KJ, Fu Y, Skory CD, Edwards JE, Spellberg B. Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis. J Infect Dis. 2008 Oct 01; 198(7):1083-90. PMID: 18694335.
      View in: PubMed
    327. Kasai M, Harrington SM, Francesconi A, Petraitis V, Petraitiene R, Beveridge MG, Knudsen T, Milanovich J, Cotton MP, Hughes J, Schaufele RL, Sein T, Bacher J, Murray PR, Kontoyiannis DP, Walsh TJ. Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol. 2008 Nov; 46(11):3690-702. PMID: 18845827.
      View in: PubMed
    328. Garcia-Effron G, Kontoyiannis DP, Lewis RE, Perlin DS. Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrob Agents Chemother. 2008 Nov; 52(11):4181-3. PMID: 18794386.
      View in: PubMed
    329. Raad II, Hachem RY, Hanna HA, Fang X, Jiang Y, Dvorak T, Sherertz RJ, Kontoyiannis DP. Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int J Antimicrob Agents. 2008 Dec; 32(6):515-8. PMID: 18783924.
      View in: PubMed
    330. Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BE. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008 Sep 01; 47(5):674-83. PMID: 18637757.
      View in: PubMed
    331. Lionakis MS, Samonis G, Kontoyiannis DP. Endocrine and metabolic manifestations of invasive fungal infections and systemic antifungal treatment. Mayo Clin Proc. 2008 Sep; 83(9):1046-60. PMID: 18775205.
      View in: PubMed
    332. Atkinson BJ, Lewis RE, Kontoyiannis DP. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med Mycol. 2008 Sep; 46(6):541-6. PMID: 19180749.
      View in: PubMed
    333. Lewis RE, Albert ND, Kontoyiannis DP. Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2008 Nov; 52(11):4178-80. PMID: 18725439.
      View in: PubMed
    334. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008 Aug 15; 47(4):503-9. PMID: 18611163.
      View in: PubMed
    335. Walsh TJ, Kontoyiannis DP. Editorial commentary: what is the role of combination therapy in management of zygomycosis? Clin Infect Dis. 2008 Aug 01; 47(3):372-4. PMID: 18558877.
      View in: PubMed
    336. Lewis RE, Kontoyiannis DP. Invasive aspergillosis in glucocorticoid-treated patients. Med Mycol. 2009; 47 Suppl 1:S271-81. PMID: 18654923.
      View in: PubMed
    337. Ben-Ami R, Lewis RE, Kontoyiannis DP. Immunocompromised hosts: immunopharmacology of modern antifungals. Clin Infect Dis. 2008 Jul 15; 47(2):226-35. PMID: 18540822.
      View in: PubMed
    338. Lamaris GA, Lewis RE, Chamilos G, May GS, Safdar A, Walsh TJ, Raad II, Kontoyiannis DP. Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis. 2008 Jul 15; 198(2):186-92. PMID: 18500936.
      View in: PubMed
    339. Chamilos G, Lewis RE, Hu J, Xiao L, Zal T, Gilliet M, Halder G, Kontoyiannis DP. Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci U S A. 2008 Jul 08; 105(27):9367-72. PMID: 18583479.
      View in: PubMed
    340. Lamaris GA, Ben-Ami R, Lewis RE, Kontoyiannis DP. Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis. J Antimicrob Chemother. 2008 Sep; 62(3):539-42. PMID: 18544603.
      View in: PubMed
    341. Wahba H, Truong MT, Lei X, Kontoyiannis DP, Marom EM. Reversed halo sign in invasive pulmonary fungal infections. Clin Infect Dis. 2008 Jun 01; 46(11):1733-7. PMID: 18419427.
      View in: PubMed
    342. Marom EM, Holmes AM, Bruzzi JF, Truong MT, O'Sullivan PJ, Kontoyiannis DP. Imaging of pulmonary fusariosis in patients with hematologic malignancies. AJR Am J Roentgenol. 2008 Jun; 190(6):1605-9. PMID: 18492913.
      View in: PubMed
    343. Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer. 2008 Jun; 112(11):2493-9. PMID: 18412153.
      View in: PubMed
    344. Jacobson KL, Miceli MH, Tarrand JJ, Kontoyiannis DP. Legionella pneumonia in cancer patients. Medicine (Baltimore). 2008 May; 87(3):152-9. PMID: 18520324.
      View in: PubMed
    345. Awais A, Tam CS, Kontoyiannis D, Ferrajoli A, Duvic M, Cortes J, Keating MJ. Rapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemia. Clin Infect Dis. 2008 Apr 01; 46(7):e69-71. PMID: 18444808.
      View in: PubMed
    346. Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer. 2008 Mar 15; 112(6):1282-7. PMID: 18224662.
      View in: PubMed
    347. Lewis RE, Albert ND, Kontoyiannis DP. Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. J Antimicrob Chemother. 2008 May; 61(5):1140-4. PMID: 18305201.
      View in: PubMed
    348. Chamilos G, Macapinlac HA, Kontoyiannis DP. The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. Med Mycol. 2008 Feb; 46(1):23-9. PMID: 18297544.
      View in: PubMed
    349. Spikes S, Xu R, Nguyen CK, Chamilos G, Kontoyiannis DP, Jacobson RH, Ejzykowicz DE, Chiang LY, Filler SG, May GS. Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence. J Infect Dis. 2008 Feb 01; 197(3):479-86. PMID: 18199036.
      View in: PubMed
    350. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc. 2008 Feb; 83(2):181-94. PMID: 18241628.
      View in: PubMed
    351. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008 Feb 01; 46(3):327-60. PMID: 18177225.
      View in: PubMed
    352. Chamilos G, Lewis RE, Lamaris GA, Albert ND, Kontoyiannis DP. Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae. Antimicrob Agents Chemother. 2008 Apr; 52(4):1325-9. PMID: 18212113.
      View in: PubMed
    353. Lamaris GA, Esmaeli B, Chamilos G, Desai A, Chemaly RF, Raad II, Safdar A, Lewis RE, Kontoyiannis DP. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis. 2008 May; 27(5):343-7. PMID: 18183439.
      View in: PubMed
    354. Chemaly RF, Torres HA, Hachem R, Kontoyiannis DP, Safdar A, Raad II. Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica. 2008 Jan; 93(1):157-8. PMID: 18166808.
      View in: PubMed
    355. Raad II, Hanna HA, Boktour M, Jiang Y, Torres HA, Afif C, Kontoyiannis DP, Hachem RY. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia. 2008 Mar; 22(3):496-503. PMID: 18094720.
      View in: PubMed
    356. Lamaris GA, Chamilos G, Lewis RE, Kontoyiannis DP. Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster. J Infect Dis. 2007 Dec 15; 196(12):1860-4. PMID: 18190268.
      View in: PubMed
    357. Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 2008 Feb; 52(2):735-8. PMID: 18070977.
      View in: PubMed
    358. Chou LS, Lewis RE, Ippoliti C, Champlin RE, Kontoyiannis DP. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients. Pharmacotherapy. 2007 Dec; 27(12):1644-50. PMID: 18041885.
      View in: PubMed
    359. Chamilos G, Lewis RE, Lamaris G, Walsh TJ, Kontoyiannis DP. Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage. Antimicrob Agents Chemother. 2008 Feb; 52(2):722-4. PMID: 18025115.
      View in: PubMed
    360. Quezada G, Koshkina NV, Zweidler-McKay P, Zhou Z, Kontoyiannis DP, Kleinerman ES. Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis. Antimicrob Agents Chemother. 2008 Feb; 52(2):716-8. PMID: 17984233.
      View in: PubMed
    361. Qiao J, Kontoyiannis DP, Wan Z, Li R, Liu W. Antifungal activity of statins against Aspergillus species. Med Mycol. 2007 Nov; 45(7):589-93. PMID: 18033614.
      View in: PubMed
    362. Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, Raad II, Manning JT, Han X. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer. 2007 Sep 15; 110(6):1303-6. PMID: 17614303.
      View in: PubMed
    363. Mulanovich V, Lewis RE, Raad II, Kontoyiannis DP. Random plasma concentrations of voriconazole decline over time. J Infect. 2007 Nov; 55(5):e129-30. PMID: 17804077.
      View in: PubMed
    364. Chamilos G, Luna M, Lewis RE, Chemaly R, Raad II, Kontoyiannis DP. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study. Clin Ther. 2007 Sep; 29(9):1980-6. PMID: 18035197.
      View in: PubMed
    365. Mays SR, Kunishige JH, Truong E, Kontoyiannis DP, Hymes SR. Approach to the morbilliform eruption in the hematopoietic transplant patient. Semin Cutan Med Surg. 2007 Sep; 26(3):155-62. PMID: 18070682.
      View in: PubMed
    366. Lass-Flörl C, Grif K, Kontoyiannis DP. Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity. J Clin Microbiol. 2007 Aug; 45(8):2686-90. PMID: 17581930.
      View in: PubMed
    367. Wise MG, Healy M, Reece K, Smith R, Walton D, Dutch W, Renwick A, Huong J, Young S, Tarrand J, Kontoyiannis DP. Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCR. J Med Microbiol. 2007 Jun; 56(Pt 6):778-87. PMID: 17510263.
      View in: PubMed
    368. Kontoyiannis DP, Lewis RE. Posaconazole prophylaxis in hematologic cancer. N Engl J Med. 2007 May 24; 356(21):2214-5; author reply 2215-8. PMID: 17526090.
      View in: PubMed
    369. Chamilos G, Lewis RE, Albert N, Kontoyiannis DP. Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences. Antimicrob Agents Chemother. 2007 Jun; 51(6):2257-9. PMID: 17438060.
      View in: PubMed
    370. Kontoyiannis DP. Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis. Clin Infect Dis. 2007 Apr 15; 44(8):1089-90. PMID: 17366455.
      View in: PubMed
    371. Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, Chamilos G, Palella F, Kennedy L, Mullane K, Tallman MS, Evens A, Scheetz MH, Blum W, Kontoyiannis DP. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007 Apr; 39(7):425-9. PMID: 17310132.
      View in: PubMed
    372. Safdar A, Rodriguez G, Rolston KV, O'Brien S, Khouri IF, Shpall EJ, Keating MJ, Kantarjian HM, Champlin RE, Raad II, Kontoyiannis DP. High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007 Feb; 39(3):157-64. PMID: 17245424.
      View in: PubMed
    373. Kontoyiannis DP, Chamilos G, Hassan SA, Lewis RE, Albert ND, Tarrand JJ. Increased culture recovery of Zygomycetes under physiologic temperature conditions. Am J Clin Pathol. 2007 Feb; 127(2):208-12. PMID: 17210526.
      View in: PubMed
    374. Lewis RE, Liao G, Hou J, Chamilos G, Prince RA, Kontoyiannis DP. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2007 Apr; 51(4):1253-8. PMID: 17261624.
      View in: PubMed
    375. Kontoyiannis D. [Addressing the "Hot Spots" in the management of invasive aspergillosis]. Med Mal Infect. 2007; 37 Suppl 2:9-11. PMID: 17933659.
      View in: PubMed
    376. Chamilos G, Lionakis MS, Lewis RE, Kontoyiannis DP. Role of mini-host models in the study of medically important fungi. Lancet Infect Dis. 2007 Jan; 7(1):42-55. PMID: 17182343.
      View in: PubMed
    377. Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004. Eur J Clin Microbiol Infect Dis. 2007 Jan; 26(1):13-20. PMID: 17200840.
      View in: PubMed
    378. Lewis RE, Chamilos G, Prince RA, Kontoyiannis DP. Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice. Antimicrob Agents Chemother. 2007 Mar; 51(3):1078-81. PMID: 17194825.
      View in: PubMed
    379. Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DP. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin Infect Dis. 2006 Dec 15; 43(12):1580-4. PMID: 17109292.
      View in: PubMed
    380. Almyroudis NG, Kontoyiannis DP, Sepkowitz KA, DePauw BE, Walsh TJ, Segal BH. Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection. Clin Infect Dis. 2006 Dec 01; 43(11):1449-55. PMID: 17083020.
      View in: PubMed
    381. Chamilos G, Lewis RE, Kontoyiannis DP. Multidrug-resistant endosymbiotic bacteria account for the emergence of zygomycosis: A hypothesis. Fungal Genet Biol. 2007 Feb; 44(2):88-92. PMID: 16990037.
      View in: PubMed
    382. Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T. Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis. 2006 Oct 15; 43(8):1031-9. PMID: 16983616.
      View in: PubMed
    383. Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006 Sep; 20(3):581-607, vi. PMID: 16984870.
      View in: PubMed
    384. Chamilos G, Kontoyiannis DP. Defining the diagnosis of invasive aspergillosis. Med Mycol. 2006 Sep 01; 44(Supplement_1):S163-S173. PMID: 30408899.
      View in: PubMed
    385. Chamilos G, Kontoyiannis DP. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine. Curr Opin Infect Dis. 2006 Aug; 19(4):380-5. PMID: 16804387.
      View in: PubMed
    386. Kumashi PR, Safdar A, Chamilos G, Chemaly RF, Raad II, Kontoyiannis DP. Fungal osteoarticular infections in patients treated at a comprehensive cancer centre: a 10-year retrospective review. Clin Microbiol Infect. 2006 Jul; 12(7):621-6. PMID: 16774557.
      View in: PubMed
    387. Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, Shpall EJ, Raad II, Kantarjian HM, Champlin RE. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions. Cancer. 2006 Jun 15; 106(12):2664-71. PMID: 16691620.
      View in: PubMed
    388. Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, Safdar A, Raad II, Kontoyiannis DP. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006 Jul; 91(7):986-9. PMID: 16757415.
      View in: PubMed
    389. Torres HA, Chemaly RF, Storey R, Aguilera EA, Nogueras GM, Safdar A, Rolston KV, Raad II, Kontoyiannis DP. Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients. Eur J Clin Microbiol Infect Dis. 2006 Jun; 25(6):382-8. PMID: 16767486.
      View in: PubMed
    390. Garey KW, Neuhauser MM, Bearden DT, Cannon JP, Lewis RE, Gentry LO, Kontoyiannis DP. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study. Mycoses. 2006 May; 49(3):226-31. PMID: 16681815.
      View in: PubMed
    391. Sipsas NV, Kontoyiannis DP. Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies. Clin Infect Dis. 2006 Jun 01; 42(11):1584-91. PMID: 16652316.
      View in: PubMed
    392. Raad II, Hachem RY, Herbrecht R, Graybill JR, Hare R, Corcoran G, Kontoyiannis DP. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis. 2006 May 15; 42(10):1398-403. PMID: 16619151.
      View in: PubMed
    393. Torres HA, Kontoyiannis DP, Aguilera EA, Younes A, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma. 2006 Mar; 6(5):393-8. PMID: 16640816.
      View in: PubMed
    394. Yusuf SW, Ali SS, Swafford J, Durand JB, Bodey GP, Chemaly RF, Kontoyiannis DP, Tarrand J, Rolston KV, Yeh E, Raad II, Safdar A. Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004. Medicine (Baltimore). 2006 Mar; 85(2):86-94. PMID: 16609347.
      View in: PubMed
    395. Chamilos G, Lionakis MS, Lewis RE, Lopez-Ribot JL, Saville SP, Albert ND, Halder G, Kontoyiannis DP. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis. 2006 Apr 01; 193(7):1014-22. PMID: 16518764.
      View in: PubMed
    396. van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006 Apr 01; 42(7):e61-5. PMID: 16511748.
      View in: PubMed
    397. Chamilos G, Kontoyiannis DP. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resist Updat. 2005 Dec; 8(6):344-58. PMID: 16488654.
      View in: PubMed
    398. Singh N, Limaye AP, Forrest G, Safdar N, Muñoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton P, Del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM, Lewis RE, Kontoyiannis DP, Husain S. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation. 2006 Feb 15; 81(3):320-6. PMID: 16477215.
      View in: PubMed
    399. Wiederhold NP, Tam VH, Chi J, Prince RA, Kontoyiannis DP, Lewis RE. Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2006 Feb; 50(2):469-73. PMID: 16436698.
      View in: PubMed
    400. Ullmann AJ, Cornely OA, Burchardt A, Hachem R, Kontoyiannis DP, Töpelt K, Courtney R, Wexler D, Krishna G, Martinho M, Corcoran G, Raad I. Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother. 2006 Feb; 50(2):658-66. PMID: 16436724.
      View in: PubMed
    401. Chamilos G, Lewis RE, Kontoyiannis DP. Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin. Antimicrob Agents Chemother. 2006 Feb; 50(2):744-7. PMID: 16436735.
      View in: PubMed
    402. Rolston KV, Yadegarynia D, Kontoyiannis DP, Raad II, Ho DH. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients. Int J Infect Dis. 2006 May; 10(3):223-30. PMID: 16439177.
      View in: PubMed
    403. Lionakis MS, Chamilos G, Lewis RE, Wiederhold NP, Raad II, Samonis G, Kontoyiannis DP. Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis. Antimicrob Agents Chemother. 2006 Jan; 50(1):294-7. PMID: 16377700.
      View in: PubMed
    404. Chamilos G, Lewis RE, Kontoyiannis DP. Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother. 2006 Jan; 50(1):96-103. PMID: 16377673.
      View in: PubMed
    405. Lewis RE, Wiederhold NP, Prince RA, Kontoyiannis DP. In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin. J Antimicrob Chemother. 2006 Feb; 57(2):288-93. PMID: 16387749.
      View in: PubMed
    406. Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis. 2005 Dec; 5(12):775-85. PMID: 16310149.
      View in: PubMed
    407. Lewis RE, Wiederhold NP, Lionakis MS, Prince RA, Kontoyiannis DP. Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. J Clin Microbiol. 2005 Dec; 43(12):6120-2. PMID: 16333108.
      View in: PubMed
    408. Wiederhold NP, Kontoyiannis DP, Prince RA, Lewis RE. Attenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathways. Antimicrob Agents Chemother. 2005 Dec; 49(12):5146-8. PMID: 16304189.
      View in: PubMed
    409. Lionakis MS, Lahdenranta J, Sun J, Liu W, Lewis RE, Albert ND, Pasqualini R, Arap W, Kontoyiannis DP. Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis. Infect Immun. 2005 Nov; 73(11):7747-58. PMID: 16239579.
      View in: PubMed
    410. Chamilos G, Kontoyiannis DP. Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis. J Infect. 2005 Nov; 51(4):e225-8. PMID: 16291275.
      View in: PubMed
    411. Pagano L, Gleissner B, Fianchi L. Breakthrough zygomycosis and voriconazole. J Infect Dis. 2005 Oct 15; 192(8):1496-7; author reply 1497. PMID: 16170771.
      View in: PubMed
    412. Healy M, Reece K, Walton D, Huong J, Frye S, Raad II, Kontoyiannis DP. Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol. 2005 Oct; 43(10):5278-80. PMID: 16207996.
      View in: PubMed
    413. Ostrosky-Zeichner L, Kontoyiannis D, Raffalli J, Mullane KM, Vazquez J, Anaissie EJ, Lipton J, Jacobs P, van Rensburg JH, Rex JH, Lau W, Facklam D, Buell DN. International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia. Eur J Clin Microbiol Infect Dis. 2005 Oct; 24(10):654-61. PMID: 16261306.
      View in: PubMed
    414. Lewis RE, Kontoyiannis DP. Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro. J Antimicrob Chemother. 2005 Nov; 56(5):887-92. PMID: 16188916.
      View in: PubMed
    415. Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005 Oct; 41(15):2268-79. PMID: 16143517.
      View in: PubMed
    416. Lionakis MS, Lewis RE, Chamilos G, Kontoyiannis DP. Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy. Pharmacotherapy. 2005 Sep; 25(9):1174-80. PMID: 16164392.
      View in: PubMed
    417. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005 Sep 01; 41(5):634-53. PMID: 16080086.
      View in: PubMed
    418. John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect. 2005 Jul; 11(7):515-7. PMID: 15966968.
      View in: PubMed
    419. Kontoyiannis DP, Boktour M, Hanna H, Torres HA, Hachem R, Raad II. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer. 2005 Jun 01; 103(11):2334-7. PMID: 15844093.
      View in: PubMed
    420. Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis. 2005 Jul 01; 41(1):60-6. PMID: 15937764.
      View in: PubMed
    421. May GS, Xue T, Kontoyiannis DP, Gustin MC. Mitogen activated protein kinases of Aspergillus fumigatus. Med Mycol. 2005 May; 43 Suppl 1:S83-6. PMID: 16110797.
      View in: PubMed
    422. Lionakis MS, Lewis RE, Torres HA, Albert ND, Raad II, Kontoyiannis DP. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Microbiol Infect Dis. 2005 May; 52(1):15-20. PMID: 15878437.
      View in: PubMed
    423. Morgan J, Wannemuehler KA, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ, Fridkin SK, Pappas PG, Warnock DW. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol. 2005 May; 43 Suppl 1:S49-58. PMID: 16110792.
      View in: PubMed
    424. Lionakis MS, Kontoyiannis DP. Fruit flies as a minihost model for studying drug activity and virulence in Aspergillus. Med Mycol. 2005 May; 43 Suppl 1:S111-4. PMID: 16110801.
      View in: PubMed
    425. Lionakis MS, Kontoyiannis DP. Sinus zygomycosis in a patient receiving voriconazole prophylaxis. Br J Haematol. 2005 Apr; 129(1):2. PMID: 15801950.
      View in: PubMed
    426. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 2005 Apr 15; 191(8):1350-60. PMID: 15776383.
      View in: PubMed
    427. Sipsas NV, Bodey GP, Kontoyiannis DP. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer. 2005 Mar 15; 103(6):1103-13. PMID: 15666328.
      View in: PubMed
    428. Rolston KV, Kontoyiannis DP, Yadegarynia D, Raad II. Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones. Diagn Microbiol Infect Dis. 2005 Mar; 51(3):215-8. PMID: 15766609.
      View in: PubMed
    429. Lionakis MS, Lewis RE, May GS, Wiederhold NP, Albert ND, Halder G, Kontoyiannis DP. Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence. J Infect Dis. 2005 Apr 01; 191(7):1188-95. PMID: 15747256.
      View in: PubMed
    430. Safdar A, Rodriguez G, Ohmagari N, Kontoyiannis DP, Rolston KV, Raad II, Champlin RE. The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation. Cancer. 2005 Feb 15; 103(4):731-9. PMID: 15641032.
      View in: PubMed
    431. Kontoyiannis DP, Lewis RE. Caspofungin versus liposomal amphotericin B for empirical therapy. N Engl J Med. 2005 Jan 27; 352(4):410-4; author reply 410-4. PMID: 15673808.
      View in: PubMed
    432. Torres HA, Prieto VG, Raad II, Kontoyiannis DP. Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact Cr. neoformans. Mycoses. 2005 Jan; 48(1):21-4. PMID: 15679661.
      View in: PubMed
    433. Lewis RE, Wiederhold NP, Chi J, Han XY, Komanduri KV, Kontoyiannis DP, Prince RA. Detection of gliotoxin in experimental and human aspergillosis. Infect Immun. 2005 Jan; 73(1):635-7. PMID: 15618207.
      View in: PubMed
    434. Tarrand JJ, Han XY, Kontoyiannis DP, May GS. Aspergillus hyphae in infected tissue: evidence of physiologic adaptation and effect on culture recovery. J Clin Microbiol. 2005 Jan; 43(1):382-6. PMID: 15634998.
      View in: PubMed
    435. Safdar A, Hanna HA, Boktour M, Kontoyiannis DP, Hachem R, Lichtiger B, Freireich EJ, Raad II. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections. Cancer. 2004 Dec 15; 101(12):2859-65. PMID: 15529309.
      View in: PubMed
    436. Karatzi K, Papamichael C, Aznaouridis K, Karatzis E, Lekakis J, Matsouka C, Boskou G, Chiou A, Sitara M, Feliou G, Kontoyiannis D, Zampelas A, Mavrikakis M. Constituents of red wine other than alcohol improve endothelial function in patients with coronary artery disease. Coron Artery Dis. 2004 Dec; 15(8):485-90. PMID: 15585989.
      View in: PubMed
    437. Stanzani M, Orciuolo E, Lewis R, Kontoyiannis DP, Martins SL, St John LS, Komanduri KV. Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood. 2005 Mar 15; 105(6):2258-65. PMID: 15546954.
      View in: PubMed
    438. Ohmagari N, Raad II, Hachem R, Kontoyiannis DP. Invasive aspergillosis in patients with solid tumors. Cancer. 2004 Nov 15; 101(10):2300-2. PMID: 15452832.
      View in: PubMed
    439. Montes M, White AC, Kontoyiannis DP. Symptoms of intestinal schistosomiasis presenting during treatment of large B cell lymphoma. Am J Trop Med Hyg. 2004 Nov; 71(5):552-3. PMID: 15569782.
      View in: PubMed
    440. Boktour MR, Kontoyiannis DP, Hanna HA, Hachem RY, Girgawy E, Bodey GP, Raad II. Multiple-species candidemia in patients with cancer. Cancer. 2004 Oct 15; 101(8):1860-5. PMID: 15386338.
      View in: PubMed
    441. Liu W, May GS, Kontoyiannis DP, Li RY. [Cloning of the Aspergillus fumigatus squalene epoxidase gene]. Beijing Da Xue Xue Bao Yi Xue Ban. 2004 Oct; 36(5):476-82. PMID: 15489926.
      View in: PubMed
    442. Lionakis MS, Bodey GP, Tarrand JJ, Raad II, Kontoyiannis DP. The significance of blood cultures positive for emerging saprophytic moulds in cancer patients. Clin Microbiol Infect. 2004 Oct; 10(10):922-5. PMID: 15373888.
      View in: PubMed
    443. Hachem RY, Kontoyiannis DP, Boktour MR, Afif C, Cooksley C, Bodey GP, Chatzinikolaou I, Perego C, Kantarjian HM, Raad II. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer. 2004 Oct 01; 101(7):1594-600. PMID: 15378491.
      View in: PubMed
    444. Wiederhold NP, Kontoyiannis DP, Chi J, Prince RA, Tam VH, Lewis RE. Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. J Infect Dis. 2004 Oct 15; 190(8):1464-71. PMID: 15378439.
      View in: PubMed
    445. Xue T, Nguyen CK, Romans A, Kontoyiannis DP, May GS. Isogenic auxotrophic mutant strains in the Aspergillus fumigatus genome reference strain AF293. Arch Microbiol. 2004 Nov; 182(5):346-53. PMID: 15365692.
      View in: PubMed
    446. Healy M, Reece K, Walton D, Huong J, Shah K, Kontoyiannis DP. Identification to the species level and differentiation between strains of Aspergillus clinical isolates by automated repetitive-sequence-based PCR. J Clin Microbiol. 2004 Sep; 42(9):4016-24. PMID: 15364984.
      View in: PubMed
    447. Lewis RE, Kontoyiannis DP, Kantoyiannis DP. Challenges in designing animal studies to detect antagonism of polyene activity. Antimicrob Agents Chemother. 2004 Aug; 48(8):3211; author reply 3211-2. PMID: 15273155.
      View in: PubMed
    448. De La Rosa GR, Jacobson KL, Rolston KV, Raad II, Kontoyiannis DP, Safdar A. Mycobacterium tuberculosis at a comprehensive cancer centre: active disease in patients with underlying malignancy during 1990-2000. Clin Microbiol Infect. 2004 Aug; 10(8):749-52. PMID: 15301678.
      View in: PubMed
    449. Kontoyiannis DP, Lewis RE. Toward more effective antifungal therapy: the prospects of combination therapy. Br J Haematol. 2004 Jul; 126(2):165-75. PMID: 15238137.
      View in: PubMed
    450. Liu W, May GS, Lionakis MS, Lewis RE, Kontoyiannis DP. Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus. Antimicrob Agents Chemother. 2004 Jul; 48(7):2490-6. PMID: 15215099.
      View in: PubMed
    451. Steinbach WJ, Benjamin DK, Kontoyiannis DP, Perfect JR, Lutsar I, Marr KA, Lionakis MS, Torres HA, Jafri H, Walsh TJ. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis. 2004 Jul 15; 39(2):192-8. PMID: 15307028.
      View in: PubMed
    452. Couriel D, Saliba R, Hicks K, Ippoliti C, de Lima M, Hosing C, Khouri I, Andersson B, Gajewski J, Donato M, Anderlini P, Kontoyiannis DP, Cohen A, Martin T, Giralt S, Champlin R. Tumor necrosis factor-alpha blockade for the treatment of acute GVHD. Blood. 2004 Aug 01; 104(3):649-54. PMID: 15069017.
      View in: PubMed
    453. Anatoliotaki M, Valatas V, Mantadakis E, Apostolakou H, Mavroudis D, Georgoulias V, Rolston KV, Kontoyiannis DP, Galanakis E, Samonis G. Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome. Infection. 2004 Apr; 32(2):65-71. PMID: 15057569.
      View in: PubMed
    454. Lionakis MS, Kontoyiannis DP. Fusarium infections in critically ill patients. Semin Respir Crit Care Med. 2004 Apr; 25(2):159-69. PMID: 16088459.
      View in: PubMed
    455. Raad I, Hanna H, Boktour M, Girgawy E, Danawi H, Mardani M, Kontoyiannis D, Darouiche R, Hachem R, Bodey GP. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis. 2004 Apr 15; 38(8):1119-27. PMID: 15095217.
      View in: PubMed
    456. Torres HA, Kontoyiannis DP, Rolston KV. High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study. Support Care Cancer. 2004 Jul; 12(7):511-6. PMID: 14986077.
      View in: PubMed
    457. Mattiuzzi GN, Kantarjian H, Faderl S, Lim J, Kontoyiannis D, Thomas D, Wierda W, Raad I, Garcia-Manero G, Zhou X, Ferrajoli A, Bekele N, Estey E. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy. Cancer. 2004 Feb 01; 100(3):581-9. PMID: 14745876.
      View in: PubMed
    458. Mattiuzzi GN, Kantarjian H, O'Brien S, Kontoyiannis DP, Giles F, Zhou X, Lim J, Bekele BN, Faderl S, Cortes J, Pierce S, Leitz GJ, Raad I, Estey E. Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy. Cancer. 2004 Feb 01; 100(3):568-73. PMID: 14745874.
      View in: PubMed
    459. Lionakis MS, Kontoyiannis DP. The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer. Cancer. 2004 Jan 01; 100(1):165-72. PMID: 14692037.
      View in: PubMed
    460. Kontoyiannis DP, Bodey GP, Hanna H, Hachem R, Boktour M, Girgaway E, Mardani M, Raad II. Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery. Leuk Lymphoma. 2004 Jan; 45(1):139-41. PMID: 15061210.
      View in: PubMed
    461. Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, Raad II. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis. 2004; 36(8):564-9. PMID: 15370667.
      View in: PubMed
    462. Wiederhold NP, Lewis RE, Kontoyiannis DP. Invasive aspergillosis in patients with hematologic malignancies. Pharmacotherapy. 2003 Dec; 23(12):1592-610. PMID: 14695039.
      View in: PubMed
    463. Antoniadou A, Kontoyiannis DP. Status of combination therapy for refractory mycoses. Curr Opin Infect Dis. 2003 Dec; 16(6):539-45. PMID: 14624103.
      View in: PubMed
    464. Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet. 2003 Nov 29; 362(9398):1828-38. PMID: 14654323.
      View in: PubMed
    465. Torres HA, Raad II, Kontoyiannis DP. Infections caused by Fusarium species. J Chemother. 2003 Nov; 15 Suppl 2:28-35. PMID: 14708964.
      View in: PubMed
    466. Liu W, Lionakis MS, Lewis RE, Wiederhold N, May GS, Kontoyiannis DP. Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole. Antimicrob Agents Chemother. 2003 Nov; 47(11):3592-7. PMID: 14576123.
      View in: PubMed
    467. Lionakis MS, Lewis RE, Samonis G, Kontoyiannis DP. Pentamidine is active in vitro against Fusarium species. Antimicrob Agents Chemother. 2003 Oct; 47(10):3252-9. PMID: 14506038.
      View in: PubMed
    468. Kontoyiannis DP, Lewis RE. Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far. Drug Resist Updat. 2003 Oct; 6(5):257-69. PMID: 14643296.
      View in: PubMed
    469. Rivero GA, Torres HA, Rolston KV, Kontoyiannis DP. Listeria monocytogenes infection in patients with cancer. Diagn Microbiol Infect Dis. 2003 Oct; 47(2):393-8. PMID: 14522512.
      View in: PubMed
    470. Kontoyiannis DP, Lewis RE, Lionakis MS, Albert ND, May GS, Raad II. Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity. Diagn Microbiol Infect Dis. 2003 Oct; 47(2):415-9. PMID: 14522515.
      View in: PubMed
    471. Han XY, Weinberg JS, Prabhu SS, Hassenbusch SJ, Fuller GN, Tarrand JJ, Kontoyiannis DP. Fusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis. J Neurosurg. 2003 Oct; 99(4):693-700. PMID: 14567605.
      View in: PubMed
    472. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore). 2003 Sep; 82(5):309-21. PMID: 14530780.
      View in: PubMed
    473. Raad II, Escalante C, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey EE, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KV. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer. 2003 Sep 01; 98(5):1039-47. PMID: 12942573.
      View in: PubMed
    474. Ferrajoli A, O'Brien SM, Cortes JE, Giles FJ, Thomas DA, Faderl S, Kurzrock R, Lerner S, Kontoyiannis DP, Keating MJ. Phase II study of alemtuzumab in chronic lymphoproliferative disorders. Cancer. 2003 Aug 15; 98(4):773-8. PMID: 12910522.
      View in: PubMed
    475. Torres HA, Bodey GP, Tarrand JJ, Kontoyiannis DP. Protothecosis in patients with cancer: case series and literature review. Clin Microbiol Infect. 2003 Aug; 9(8):786-92. PMID: 14616698.
      View in: PubMed
    476. Kontoyiannis DP, Chagua MR, Ramirez I, Prieto V. Locally invasive auricular aspergillosis after ear piercing in a neutropenic patient with leukemia. Am J Hematol. 2003 Aug; 73(4):296-7. PMID: 12879439.
      View in: PubMed
    477. Maraki S, Margioris AN, Orfanoudaki E, Tselentis Y, Koumantakis E, Kontoyiannis DP, Rovithi M, Samonis G. Effects of doxycycline, metronidazole and their combination on Candida species colonization of the human oropharynx, intestinal lumen and vagina. J Chemother. 2003 Aug; 15(4):369-73. PMID: 12962365.
      View in: PubMed
    478. Kontoyiannis DP, Hachem R, Lewis RE, Rivero GA, Torres HA, Thornby J, Champlin R, Kantarjian H, Bodey GP, Raad II. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer. 2003 Jul 15; 98(2):292-9. PMID: 12872348.
      View in: PubMed
    479. Torres HA, Bodey GP, Rolston KV, Kantarjian HM, Raad II, Kontoyiannis DP. Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer. 2003 Jul 01; 98(1):86-93. PMID: 12833460.
      View in: PubMed
    480. Kontoyiannis DP. What is the significance of an isolated positive cryptococcal antigen in the cerebrospinal fluid of cancer patients? Mycoses. 2003 Jun; 46(5-6):161-3. PMID: 12801355.
      View in: PubMed
    481. Tarrand JJ, Lichterfeld M, Warraich I, Luna M, Han XY, May GS, Kontoyiannis DP. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol. 2003 Jun; 119(6):854-8. PMID: 12817433.
      View in: PubMed
    482. Kontoyiannis DP, Murray PJ. Fluconazole toxicity is independent of oxidative stress and apoptotic effector mechanisms in Saccharomyces cerevisiae. Mycoses. 2003 Jun; 46(5-6):183-6. PMID: 12801359.
      View in: PubMed
    483. Hicks KL, Chemaly RF, Kontoyiannis DP. Common community respiratory viruses in patients with cancer: more than just "common colds". Cancer. 2003 May 15; 97(10):2576-87. PMID: 12733157.
      View in: PubMed
    484. Kontoyiannis DP, Pasqualini R, Arap W. Aminopeptidase N inhibitors and SARS. Lancet. 2003 May 03; 361(9368):1558. PMID: 12737884.
      View in: PubMed
    485. Torres HA, Rivero GA, Lewis RE, Hachem R, Raad II, Kontoyiannis DP. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2003 May; 46(1):25-8. PMID: 12742315.
      View in: PubMed
    486. Kontoyiannis DP, Mantadakis E, Samonis G. Systemic mycoses in the immunocompromised host: an update in antifungal therapy. J Hosp Infect. 2003 Apr; 53(4):243-58. PMID: 12660121.
      View in: PubMed
    487. Mattiuzzi GN, Cortes JE, Talpaz M, Reuben J, Rios MB, Shan J, Kontoyiannis D, Giles FJ, Raad I, Verstovsek S, Ferrajoli A, Kantarjian HM. Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate. Clin Cancer Res. 2003 Mar; 9(3):976-80. PMID: 12631595.
      View in: PubMed
    488. Kontoyiannis DP, Lewis RE, Osherov N, Albert ND, May GS. Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J Antimicrob Chemother. 2003 Feb; 51(2):313-6. PMID: 12562696.
      View in: PubMed
    489. Mattiuzzi GN, Estey E, Raad I, Giles F, Cortes J, Shen Y, Kontoyiannis D, Koller C, Munsell M, Beran M, Kantarjian H. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome. Cancer. 2003 Jan 15; 97(2):450-6. PMID: 12518369.
      View in: PubMed
    490. Pham AS, Tarrand JJ, May GS, Lee MS, Kontoyiannis DP, Han XY. Diagnosis of invasive mold infection by real-time quantitative PCR. Am J Clin Pathol. 2003 Jan; 119(1):38-44. PMID: 12520695.
      View in: PubMed
    491. Kontoyiannis DP, Lewis RE, May GS, Osherov N, Rinaldi MG. Aspergillus nidulans is frequently resistant to amphotericin B. Mycoses. 2002 Nov; 45(9-10):406-7. PMID: 12421291.
      View in: PubMed
    492. Bodey GP, Boktour M, Mays S, Duvic M, Kontoyiannis D, Hachem R, Raad I. Skin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002 Nov; 47(5):659-66. PMID: 12399756.
      View in: PubMed
    493. Lewis RE, Kontoyiannis DP, Darouiche RO, Raad II, Prince RA. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother. 2002 Nov; 46(11):3499-505. PMID: 12384356.
      View in: PubMed
    494. Lewis RE, Prince RA, Chi J, Kontoyiannis DP. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2002 Oct; 46(10):3208-14. PMID: 12234846.
      View in: PubMed
    495. Kontoyiannis DP, Reddy BT, Hanna H, Bodey GP, Tarrand J, Raad II. Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity. Infect Control Hosp Epidemiol. 2002 Sep; 23(9):542-5. PMID: 12269454.
      View in: PubMed
    496. Torres HA, Reddy BT, Raad II, Tarrand J, Bodey GP, Hanna HA, Rolston KV, Kontoyiannis DP. Nocardiosis in cancer patients. Medicine (Baltimore). 2002 Sep; 81(5):388-97. PMID: 12352633.
      View in: PubMed
    497. Raad I, Tarrand J, Hanna H, Albitar M, Janssen E, Boktour M, Bodey G, Mardani M, Hachem R, Kontoyiannis D, Whimbey E, Rolston K. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol. 2002 Sep; 23(9):532-7. PMID: 12269452.
      View in: PubMed
    498. Keating MJ, O'Brien S, Kontoyiannis D, Plunkett W, Koller C, Beran M, Lerner S, Kantarjian H. Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia. Leuk Lymphoma. 2002 Sep; 43(9):1755-62. PMID: 12685828.
      View in: PubMed
    499. Osherov N, May GS, Albert ND, Kontoyiannis DP. Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae. Antimicrob Agents Chemother. 2002 Aug; 46(8):2462-9. PMID: 12121919.
      View in: PubMed
    500. Shaikh ZH, Torres HA, Walsh GL, Champlin RE, Kontoyiannis DP. Open lung biopsy in bone marrow transplant recipients has a poor diagnostic yield for a specific diagnosis. Transpl Infect Dis. 2002 Jun; 4(2):80-4. PMID: 12220244.
      View in: PubMed
    501. Torres HA, Rivero GA, Kontoyiannis DP. Endemic mycoses in a cancer hospital. Medicine (Baltimore). 2002 May; 81(3):201-12. PMID: 11997717.
      View in: PubMed
    502. Kontoyiannis DP. Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis. Clin Infect Dis. 2002 May 01; 34(9):1281-3; author reply 1283. PMID: 11941561.
      View in: PubMed
    503. Lewis RE, Lo HJ, Raad II, Kontoyiannis DP. Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth. Antimicrob Agents Chemother. 2002 Apr; 46(4):1153-5. PMID: 11897612.
      View in: PubMed
    504. Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, Hachem RY, Kontoyiannis DP, Raad II. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med. 2002 Apr 01; 112(5):380-5. PMID: 11904112.
      View in: PubMed
    505. Samonis G, Maraki S, Anatoliotakis N, Anatoliotaki M, Apostolakou H, Margioris AN, Tselentis Y, Kontoyiannis DP. Effects of erythromycin, clarithromycin, roxithromycin and azithromycin on murine gut colonization by Candida albicans. Med Mycol. 2002 Apr; 40(2):139-42. PMID: 12058726.
      View in: PubMed
    506. Nannini EC, Keating M, Binstock P, Samonis G, Kontoyiannis DP. Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine. J Infect. 2002 Apr; 44(3):201-3. PMID: 12099753.
      View in: PubMed
    507. Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi. Lancet. 2002 Mar 30; 359(9312):1135-44. PMID: 11943280.
      View in: PubMed
    508. Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis. 2002 Mar; 21(3):161-72. PMID: 11957017.
      View in: PubMed
    509. De La Rosa GR, Champlin RE, Kontoyiannis DP. Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients. Transpl Infect Dis. 2002 Mar; 4(1):3-9. PMID: 12123420.
      View in: PubMed
    510. Reddy BT, Torres HA, Kontoyiannis DP. Breast implant infection caused by Trichosporon beigelii. Scand J Infect Dis. 2002; 34(2):143-4. PMID: 11928852.
      View in: PubMed
    511. Kontoyiannis DP, Reddy BT, Torres HA, Luna M, Lewis RE, Tarrand J, Bodey GP, Raad II. Pulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis. 2002 Feb 01; 34(3):400-3. PMID: 11774088.
      View in: PubMed
    512. Kontoyiannis DP, May GS. Identification of azole-responsive genes by microarray technology: why are we missing the efflux transporter genes? Antimicrob Agents Chemother. 2001 Dec; 45(12):3674-6. PMID: 11724035.
      View in: PubMed
    513. Kontoyiannis DP, Vaziri I, Hanna HA, Boktour M, Thornby J, Hachem R, Bodey GP, Raad II. Risk Factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis. 2001 Nov 15; 33(10):1676-81. PMID: 11568858.
      View in: PubMed
    514. Lewis RE, Kontoyiannis DP. Rationale for combination antifungal therapy. Pharmacotherapy. 2001 Aug; 21(8 Pt 2):149S-164S. PMID: 11501988.
      View in: PubMed
    515. Kontoyiannis DP. A clinical perspective for the management of invasive fungal infections: focus on IDSA guidelines. Infectious Diseases Society of America. Pharmacotherapy. 2001 Aug; 21(8 Pt 2):175S-187S. PMID: 11501990.
      View in: PubMed
    516. Samonis G, Kontoyiannis DP. Infectious complications of purine analog therapy. Curr Opin Infect Dis. 2001 Aug; 14(4):409-13. PMID: 11964857.
      View in: PubMed
    517. Ghosh S, Champlin RE, Ueno NT, Anderlini P, Rolston K, Raad I, Kontoyiannis D, Jacobson K, Luna M, Tarrand J, Whimbey E. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Bone Marrow Transplant. 2001 Aug; 28(3):271-5. PMID: 11535995.
      View in: PubMed
    518. Osherov N, Kontoyiannis DP, Romans A, May GS. Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14alpha-demethylase gene, pdmA. J Antimicrob Chemother. 2001 Jul; 48(1):75-81. PMID: 11418514.
      View in: PubMed
    519. Kontoyiannis DP, Peitsch WK, Reddy BT, Whimbey EE, Han XY, Bodey GP, Rolston KV. Cryptococcosis in patients with cancer. Clin Infect Dis. 2001 Jun 01; 32(11):E145-50. PMID: 11340547.
      View in: PubMed
    520. Maraki S, Mouzas IA, Kontoyiannis DP, Chatzinikolaou I, Tselentis Y, Samonis G. Prospective evaluation of the impact of amoxicillin, clarithromycin and their combination on human gastrointestinal colonization by Candida species. Chemotherapy. 2001 May-Jun; 47(3):215-8. PMID: 11306791.
      View in: PubMed
    521. La Rosa AM, Champlin RE, Mirza N, Gajewski J, Giralt S, Rolston KV, Raad I, Jacobson K, Kontoyiannis D, Elting L, Whimbey E. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis. 2001 Mar 15; 32(6):871-6. PMID: 11247710.
      View in: PubMed
    522. Shaikh ZH, Ueno NT, Kontoyiannis DP. Fatal Salmonella group G enteritis mimicking intestinal graft-versus-host disease in a bone marrow transplant recipient. Transpl Infect Dis. 2001 Mar; 3(1):29-33. PMID: 11429037.
      View in: PubMed
    523. Kontoyiannis DP, Andersson BS, Lewis RE, Raad II. Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B. Clin Infect Dis. 2001 Mar 01; 32(5):E94-6. PMID: 11229866.
      View in: PubMed
    524. Samonis G, Maraki S, Hajiioannou I, Chatzinikolaou I, Rolston KV, Bodey GP, Kontoyiannis DP. Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans. J Chemother. 2001 Feb; 13(1):66-9. PMID: 11233803.
      View in: PubMed
    525. Kontoyiannis DP, Tarrand J, Prince R, Samonis G, Rolston KV. Effect of fluconazole on agar invasion by Candida albicans. J Med Microbiol. 2001 Jan; 50(1):78-82. PMID: 11192509.
      View in: PubMed
    526. Mavromanolakis E, Maraki S, Cranidis A, Tselentis Y, Kontoyiannis DP, Samonis G. The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans. Scand J Infect Dis. 2001; 33(6):477-8. PMID: 11450873.
      View in: PubMed
    527. Kontoyiannis DP, Bodey GP, Mantzoros CS. Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis. Mycoses. 2001; 44(5):125-35. PMID: 11486448.
      View in: PubMed
    528. Dumitru CD, Ceci JD, Tsatsanis C, Kontoyiannis D, Stamatakis K, Lin JH, Patriotis C, Jenkins NA, Copeland NG, Kollias G, Tsichlis PN. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell. 2000 Dec 22; 103(7):1071-83. PMID: 11163183.
      View in: PubMed
    529. Kontoyiannis DP, May GS. delta-aminolaevulinic acid modulates the resistance to fluconazole in a hem1 mutant of Saccharomyces cerevisiae. J Antimicrob Chemother. 2000 Dec; 46(6):1044-6. PMID: 11102434.
      View in: PubMed
    530. Tsiodras S, Samonis G, Keating MJ, Kontoyiannis DP. Infection and immunity in chronic lymphocytic leukemia. Mayo Clin Proc. 2000 Oct; 75(10):1039-54. PMID: 11040852.
      View in: PubMed
    531. Kontoyiannis DP, Lewis RE, Sagar N, May G, Prince RA, Rolston KV. Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy. Antimicrob Agents Chemother. 2000 Oct; 44(10):2915-8. PMID: 10991890.
      View in: PubMed
    532. Kontoyiannis DP, Luna MA, Samuels BI, Bodey GP. Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis. Infect Dis Clin North Am. 2000 Sep; 14(3):721-39. PMID: 10987117.
      View in: PubMed
    533. Kontoyiannis DP, Jacobson KL, Whimbey EE, Rolston KV, Raad II. Central venous catheter-associated Nocardia bacteremia: an unusual manifestation of nocardiosis. Clin Infect Dis. 2000 Aug; 31(2):617-8. PMID: 10987735.
      View in: PubMed
    534. Kontoyiannis DP. Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces cerevisiae. J Antimicrob Chemother. 2000 Aug; 46(2):191-7. PMID: 10933640.
      View in: PubMed
    535. Kontoyiannis DP. Efflux-mediated resistance to fluconazole could be modulated by sterol homeostasis in Saccharomyces cerevisiae. J Antimicrob Chemother. 2000 Aug; 46(2):199-203. PMID: 10933641.
      View in: PubMed
    536. Kontoyiannis DP, Sumoza D, Tarrand J, Bodey GP, Storey R, Raad II. Significance of aspergillemia in patients with cancer: a 10-year study. Clin Infect Dis. 2000 Jul; 31(1):188-9. PMID: 10913421.
      View in: PubMed
    537. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis. 2000 Jun; 30(6):851-6. PMID: 10852735.
      View in: PubMed
    538. Kontoyiannis DP, Rupp S. Cyclic AMP and fluconazole resistance in Saccharomyces cerevisiae. Antimicrob Agents Chemother. 2000 Jun; 44(6):1743-4. PMID: 10817746.
      View in: PubMed
    539. Kontoyiannis DP. Fluconazole inhibits pseudohyphal growth in Saccharomyces cerevisiae. Chemotherapy. 2000 Mar-Apr; 46(2):100-3. PMID: 10671759.
      View in: PubMed
    540. Kontoyiannis DP, Basgoz N. Klebsiella ozaniae empyema complicating longstanding oleothorax. Scand J Infect Dis. 2000; 32(5):582. PMID: 11055678.
      View in: PubMed
    541. Kontoyiannis DP. Genetic analysis of azole resistance by transposon mutagenesis in Saccharomyces cerevisiae. Antimicrob Agents Chemother. 1999 Nov; 43(11):2731-5. PMID: 10543755.
      View in: PubMed
    542. Kontoyiannis DP, Sagar N, Hirschi KD. Overexpression of Erg11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae. Antimicrob Agents Chemother. 1999 Nov; 43(11):2798-800. PMID: 10543768.
      View in: PubMed
    543. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 1999 Mar; 10(3):387-98. PMID: 10204494.
      View in: PubMed
    544. Anaissie EJ, Kontoyiannis DP, O'Brien S, Kantarjian H, Robertson L, Lerner S, Keating MJ. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med. 1998 Oct 01; 129(7):559-66. PMID: 9758577.
      View in: PubMed
    545. Kontoyiannis DP, Ruoff K, Hooper DC. Nocardia bacteremia. Report of 4 cases and review of the literature. Medicine (Baltimore). 1998 Jul; 77(4):255-67. PMID: 9715730.
      View in: PubMed
    546. Anaissie EJ, Darouiche RO, Abi-Said D, Uzun O, Mera J, Gentry LO, Williams T, Kontoyiannis DP, Karl CL, Bodey GP. Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin Infect Dis. 1996 Nov; 23(5):964-72. PMID: 8922787.
      View in: PubMed
    547. Anaissie EJ, Vartivarian SE, Abi-Said D, Uzun O, Pinczowski H, Kontoyiannis DP, Khoury P, Papadakis K, Gardner A, Raad II, Gilbreath J, Bodey GP. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am J Med. 1996 Aug; 101(2):170-6. PMID: 8757357.
      View in: PubMed
    548. Kontoyiannis DP, Rubin RH. Infection in the organ transplant recipient. An overview. Infect Dis Clin North Am. 1995 Dec; 9(4):811-22. PMID: 8747767.
      View in: PubMed
    549. Kontoyiannis DP, Calia KE, Basgoz N, Calderwood SB. Primary septicemia caused by Vibrio cholerae non-O1 acquired on Cape Cod, Massachusetts. Clin Infect Dis. 1995 Nov; 21(5):1330-3. PMID: 8589171.
      View in: PubMed
    550. Anaissie EJ, Kontoyiannis DP, Huls C, Vartivarian SE, Karl C, Prince RA, Bosso J, Bodey GP. Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. J Infect Dis. 1995 Aug; 172(2):599-602. PMID: 7622915.
      View in: PubMed
    551. Anaissie E, Samonis G, Kontoyiannis D, Costerton J, Sabharwal U, Bodey G, Raad I. Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis. 1995 Feb; 14(2):134-7. PMID: 7758480.
      View in: PubMed
    552. Kontoyiannis DP, Olivero JJ. Intestinal obstruction in a dialysis patient with a broken leg. Hosp Pract (Off Ed). 1994 Jan 15; 29(1):133-4. PMID: 8288685.
      View in: PubMed
    553. Anaissie EJ, Kontoyiannis DP, Vartivarian S, Kantarjian HM, O'Brien S, Giralt SA, Andersson BS, Karl C, Champlin RE, Bodey GP. Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304. Clin Infect Dis. 1993 Dec; 17(6):1022-31. PMID: 8110925.
      View in: PubMed
    554. Anaissie E, Kontoyiannis DP, Kantarjian H, Elting L, Robertson LE, Keating M. Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone. Ann Intern Med. 1992 Sep 15; 117(6):466-9. PMID: 1354425.
      View in: PubMed
    555. Kantarjian HM, Talpaz M, Kontoyiannis D, Gutterman J, Keating MJ, Estey EH, O'Brien S, Rios MB, Beran M, Deisseroth A. Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor. J Clin Oncol. 1992 Mar; 10(3):398-405. PMID: 1740679.
      View in: PubMed
    556. Anaissie E, Nelson P, Beremand M, Kontoyiannis D, Rinaldi M. Fusarium-caused hyalohyphomycosis: an overview. Curr Top Med Mycol. 1992; 4:231-49. PMID: 1732068.
      View in: PubMed
    557. Use of ceftolozane/tazobactam in the treatment of multidrug-resistant pseudomonas aeruginosa bloodstream infection in a pediatric leukemia patient. Pediatric Infectious Disease Journal. 35:1040-1042.
    558. Pathogenesis of Invasive Pulmonary Aspergillosis. 345-379.
    559. The evolving landscape of gastrointestinal infections in neutropenic patients. ONCOLOGY (United States). 29.
    560. The Burden of Bacterial and Viral Infections in Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 15:128-133.
    561. Glucocorticosteroids do not impact directly growth rate and biomass of Rhizopus arrhizus (syn. R. oryzae) in vitro. Virulence. 6:441-443.
    562. Uncommon Candida species fungemia among cancer patients, Houston, Texas, USA. Emerging Infectious Diseases. 21:1942-1950.
    563. Effect of preexposure to triazoles on susceptibility and virulence of Rhizopus oryzae. Antimicrobial Agents and Chemotherapy. 59:7830-7832.
    564. Invasive aspergillosis (IA) in patients with leukemia and bone marrow transplant patients (PTS). Blood. 96.
    565. Infections following allogeneic stem cell transplantation. Virulence. 7:898-900.
    566. Gastrointestinal mucormycosis. Gastroenterology and Hepatology. 5:661-662.
    567. Biofilm filtrates of pseudomonas aeruginosa strains isolated from cystic fibrosis patients inhibit preformed Aspergillus fumigatus biofilms via apoptosis. PLoS One. 11.
    568. Mycetoma. 2005-2007.
    569. Studying Fungal Pathogenesis in Drosophila. Microbe. 5:291-296.
    570. A man with acute myeloid leukemia, fever, and hip pain. Journal of Invasive Fungal Infections. 3:15-17.
    571. Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia. Blood. 126:2790-2797.
    572. Executive summary. Clinical Infectious Diseases. 63:433-442.
    573. Agents of Mucormycosis and Entomophthoramycosis. 2909-2919.
    574. Iron starvation induces apoptosis in rhizopus oryzae in vitro. Virulence. 6:121-126.
    575. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis. Clinical Microbiology and Infection.
    576. Invasive candidiasis in the neutropenic cancer patient. Current Fungal Infection Reports. 5:34-41.
    577. Practice guidelines for the diagnosis and management of aspergillosis. Clinical Infectious Diseases. 63:e1-e60.
    578. Immunomodulating effects of antifungal therapy. Current Fungal Infection Reports. 3:243-250.
    579. Defining the diagnosis of invasive aspergillosis. Medical Mycology. 44:163-172.
    580. Factors affecting patient outcome in primary cutaneous aspergillosis. Medicine (United States). 95.
    581. Efficacy and tolerability of micafungin monotherapy for candidemia and deep-seated candidiasis in adults with cancer. Antimicrobial Agents and Chemotherapy. 58:3526-3529.
    582. Erratum. European Journal of Clinical Microbiology and Infectious Diseases. 25:69.
    583. Correlation between circulating fungal biomarkers and clinical outcome in invasive aspergillosis. PLoS One. 10.
    584. Editorial comment. Infections in Medicine. 21:40.
    585. Erratum. Antimicrobial Agents and Chemotherapy. 48:4072.
    586. Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis. Journal of Clinical Investigation. 126:2280-2294.
    587. Micafungin in haematology. Mycoses. 55:13-23.
    588. Co-infection with influenza. Tuberculosis and Respiratory Diseases. 76:249.
    589. Treatment of mucormycosis in transplant patients. Current Opinion in Infectious Diseases.
    590. Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates. Virulence. 6:385-394.
    591. Candida arthritis. Open Forum Infectious Diseases. 3.
    592. Time-to-reporting of blood culture positivity and central venous catheter-associated Candida glabrata fungemia in cancer patients. Diagnostic Microbiology and Infectious Disease.
    593. Primary zygomycosis in cancer patients. Infections in Medicine. 22:42.
    594. Mucormycosis. 1994-1997.
    595. Implementation of a pan-genomic approach to investigate holobiont-infecting microbe interaction. PLoS One. 10.
    596. Fungal empyema thoracis in cancer patients. Journal of Infection.
    597. Aspergillus Cell Wall Melanin Blocks LC3-Associated Phagocytosis to Promote Pathogenicity. Cell Host and Microbe. 19:79-90.
    598. Albumin enhances caspofungin activity against Aspergillus species by facilitating drug delivery to germinating hyphae. Antimicrobial Agents and Chemotherapy. 60:1226-1233.
    599. Mixed angioinvasive exserohilum and scedosporium infection in a patient with AML. American Journal of Hematology.
    600. Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. American Journal of Transplantation.
    601. Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection. Virulence. 2.
    602. Disseminated cryptococcal infection in allogeneic stem cell transplant patients. Bone Marrow Transplantation. 51:1301-1304.
    603. Drosophila melanogaster as a versatile model for the discovery of drugs effective against human Microbe-induced infection and pathology. 300-309.
    604. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerging Infectious Diseases. 17:1855-1864.
    605. Erratum. Clinical Infectious Diseases. 35:110.
    606. Reply to Hoenigl et al. Clinical Infectious Diseases. 51:254-255.
    607. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients. Transplant Infectious Disease.
    608. Refractory cellulitis in a woman with chronic lymphedema. Infectious Diseases in Clinical Practice. 14:244-245.
    609. Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species. Virulence. 2.
    610. Statin Concentrations below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae. Journal of Infectious Diseases. 214:114-121.
    611. Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance. Nature Communications. 7.
    612. Antifungal agents and liver toxicity. Expert Review of Anti-Infective Therapy. 14:765-776.
    613. Erratum. Clinical Infectious Diseases. 39:1264.
    614. Erratum. Clinical Infectious Diseases. 43:1376.
    615. Mucormycoses. Infectious Disease Clinics of North America. 30:143-163.
    616. Mouse models for the study of fungal pneumonia. Virulence. 3:15.
    617. Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis. Journal of Antimicrobial Chemotherapy. 71:946-952.
    618. Subclinical tumor lysis-like syndrome during treatment of visceral leishmaniasis with low-dose intermittent liposomal amphotericin B. Central European Journal of Medicine. 7:305-309.
    619. Redundant synthesis of a conidial polyketide by two distinct secondary metabolite clusters in Aspergillus fumigatus. Environmental Microbiology. 18:246-259.
    620. Micafungin. Drugs. 64:983-984.
    621. Identification and characterization of a novel family of selective antifungal compounds (CANBEFs) that interfere with fungal protein synthesis. Antimicrobial Agents and Chemotherapy. 59:5631-5640.
    622. Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States. BMC Infectious Diseases. 16.
    623. Hyalohyphomycoses (hyaline moulds). 281-304.
    624. Invasive mold infections in pediatric cancer patients reflect heterogeneity in etiology, presentation, and outcome. Journal of the Pediatric Infectious Diseases Society. 1:125-135.
    625. Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients. Journal of Antimicrobial Chemotherapy. 71:727-730.
    KONTOYIANNIS's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description